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Eukaryotic DNA is complexed with several different proteins and exists in the form of 
chromatin. Chromatin itself is a very dynamic and fluctuating structure that is regulated 
in accordance with the function of a cell and the different signails it receives. The basic 
unit of chromatin structure is a nucleosome, which consists of histone core proteins 
H2A, H2B, H3 and H4, which form an octamer, and the DNA winds around this core. 
These histone proteins are characterized by the presence of unstructured C- and N-
terminal tails, which protrude out of each nucleosome. These tails are prone to different 
chemical modifications called post-translational modifications (PTM). Different PTM 
patterns have different effect on associated genes and lead either to gene activation or 
gene silencing. The pattern of PTMs is referred to as the histone code. Maintenance of 
the code is promoted by different enzymes that are able to “read” and “edit” these 
modifications, contributing to gene regulation. 
ASHH2 methyltransferase is a plant (Arabidopsis thaliana) protein that involved in 
regulation of more than 1000 genes. It has several domains that function in reader-
editor combination. By its CW domain ASHH2 selectively recognize monomethylated 
modification at the 4th lysine of H3 histone tail (H3K4me1) and by its SET 
methyltransferase domain it transfers a methyl group to H3K36 position and activates 
associated genes by H3K36me2/me3 modifications. 
The CW domain is also present in other protein families with different functions related 
to chromatin remodelling and gene regulation. But the CW from those families was 
shown to be more selective towards H3K4me3 modification. 
As for now, there is no consensus in what determines and selectivity of the CW 
domains and how it is regulated. The overall objective of the thesis is to explore the 
question of selectivity mechanism of the CW domain from ASHH2 methyltransferase, 
which is unique in preference towards H3K4me1 modification. Using comparative 
structural approach supplemented with biophysical analysis of interacting proteins, the 
work aimed to solve the structure of CW domain in complex with H3K4me1 peptide, 
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assess the protein’s internal dynamics and characterize the interaction mechanism 
thermodynamically. 
Paper I is an analysis and description paper documenting NMR spectra assignments of 
CW in free state and bound to peptides, which form the foundation of the NMR work 
in paper II and paper III. 
Paper II summarizes the results of solved structure and dynamics evaluation. The main 
conclusion is that CW recognizes its ligand by a conformational selection mechanism, 
as it appears as a very flexible protein, even when it is bound to the ligand. Upon ligand 
binding, CW undergoes compaction and stabilization. Stabilization of the complex 
structure is mediated by two unstructured coils flanking the C-terminal α1-helix. 
Molecular dynamic simulation, performed in comparison with the previously published 
X-ray structure, suggested also β-augmentation by the ligand.  
In Paper III, biophysical aspects of the interaction mechanism and the domain’s 
specificity were investigated, and the results showed that the interaction with the ligand 
is enthalpy driven and that the specificity towards H3K4me1 arises from different 
balances of enthalpy-entropy contributions when the domain interacts with 
H3K4me1/2/3 peptides. Mutation analysis led to the conclusion that the C-terminal α1-
helix maintains the fold of the domain through residues I915 and L919 oriented towards 
the hydrophobic tryptophan binding pocket. Point mutations resulted in the fold 
disturbances that affect the interaction in a way that it was reduced or lost, rather than 
in an overall change in the specificity of the domain. As a conclusion, selectivity was 
linked to stability of the fold maintained by α1-helix, and energetically favourable 








1.1 DNA and chromatin organization 
DNA is a central biomolecule that carries and ensures the inheritance of genetic 
information. Within eukaryotic cells, DNA exists as an association with proteins that 
help to organize it into structures called chromosomes. Such organization to a compact 
form is necessary, primarily due to limited space in the nucleus. Second, it provides 
stability to the DNA molecule, protecting it from damage. And, lastly, a chromosome 
is an efficient way to transmit genetic information during cell division [1-3]. 
Prior to the formation of chromosomes, DNA is organized and compacted via different 
intermediate structures with help of associated special proteins. These proteins and 
DNA complex at a given genomic region is referred to as chromatin. The basic unit of 
chromatin is a nucleosome, which represents “a reel” with DNA wound around an 
octamer of eight core histone proteins. The octamer is formed by two copies of each of 
H2A, H2B, H3 and H4 proteins. This level of organization is often referred to as “beads 
on string”. There is also the H1 histone protein, which is involved in next level of 
chromatin organization, the so-called chromatin fiber, by sealing the nucleosomes from 
outside, and referred to as a linker histone [3-5]. Different levels of chromatin 
organization and nucleosome structure are depicted in Figure 1 and 2. Beside histone 
proteins, there are numerous proteins that are involved in not only maintenance of 
chromatin structure, but also DNA-binding proteins that regulate replication, 
transcription and recombination, and are involved in repair mechanisms [6-9]. 
During the cell cycle, a cell utilizes different sets of genes by turning them on and off 
and regulating their expression, depending on the function of a cell or external signals 
and stimuli the cell receives [9,10]. Such alteration in the use of genetic information 
requires extensive control of compartmentalization, structuration and dynamical 
reorganization of chromatin in the nucleus, condensing the genomic regions which are 
not in use, forming heterochromatin, and allowing active transcription of genes located 
in the disordered regions of the genome, named euchromatin [2,5,11]. 
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1.2 General mechanism of transcriptional regulation in 
eukaryotes 
Transcription in eukaryotes is characterized by advanced interplay of different genomic 
regions. One region where the transcription machinery is getting assembled is called 
the promoter. Regions of individual binding sites for regulatory proteins comprise 
regulatory sequences and are often grouped in units called enhancers. Regulatory 
sequences can be located at a great distance from promoters and because of that DNA 
has to form a loop, bringing them together. That requires other regulatory features such 
as insulators and boundary elements to ensure that a given enhancer regulates only one 
gene out of several genes in its vicinity [12-16]. 
Regulation of transcription is done by proteins that bind to specific DNA sequences 
and switch the genes on and off. Thus, transcriptional regulators can be divided into 
activators and repressors. 
Eukaryotic activators have a DNA-binding site and activating regions that activate 
transcription by recruiting protein complexes to genes. That can be recruitment of 
transcription factors (the so-called Mediator complex), recruitment of nucleosome 
modifiers to “clear” the promoters that they encave, and recruitment of factors that 
stimulate Polymerase II initiation and elongation [17-20].    
As the eukaryotic DNA is present in the form of nucleosomes, regulatory sequences 
can be obstructed from recognition by regulatory proteins and transcription machinery. 
“Clearance” of these regions is carried out by the enzymes that either modify histone 
proteins in the core of a nucleosome and change how tight DNA is associated with 
them, or by the enzymes that are able to “remodel” the nucleosomes by utilizing energy 
from ATP-hydrolysis and displace nucleosomes exposing the regulatory sequences 
[21-24]. 
Transcriptional repressors work in the way opposite to the activators. Firstly, they can 
compete directly with activators for a binding site, blocking the binding of an activator. 
Repressors can also inhibit an activator or directly inhibit the activity of the whole 
transcription machinery. Finally, they can recruit histone modifiers to compact the 
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chromatin or remove modifications that are recognized by transcription machinery [25-
27]. 
Beside the modification of histone proteins to regulate transcription, the DNA molecule 
itself can be methylated and silence genes by inhibiting the binding of the transcription 
complex or its activators [28-32]. Methylation and demethylation of the DNA is 












Figure 1. Levels of chromatin organization. The DNA helix is wrapped around a 
histone octamer and form nucleosomes that further fold into a structure referred to as 
the 30-nm fiber. This fiber structure is organized into higher order structures with 
formation of chromosomes at the end. Figure from Jansen et al. [3]. 
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1.3 Epigenetic gene regulation 
The core histones are characterized by structural disorder of their C and N-terminal 
tails, which direct the DNA winding around the histone octamer upon formation of a 
nucleosome [4,5]. These unstructured tails protrude out of a nucleosome, that makes 
them prone to different enzymatically controlled covalent modifications, named post-
translational modifications (PTM). These modifications can be methylation, 
acetylation, phosphorylation, ubiquitination and more, and they have different effects 
on the associated chromatin. For example, acetylation of lysines at H3 histone at 
positions 9 (H3K9) or 14 (H3K14) will lead to activation of associated genes by 
promoting the formation of euchromatin. Methylation at H3K4 and H3K36 is also 
associated with active expression, while methylation at H3K9 and H3K27 are the 
marks of a repressed state of chromatin with tightly packed DNA. Patterns of PTMs 
and their associated functions are conserved among different species of organisms and 
can be inherited. These patterns of modification are often referred to as the histone 
code, and the inherited patterns of gene expression are called epigenetic regulation [36-
40]. Histones with modification positions are shown in Figure 2. 
Maintenance of the histone code is based on the variety of proteins which are able to 
recognize and modify the PTM state of the chromatin, playing an important role in 
regulation of gene expression. The functionality of the histone code maintenance is 
divided between protein domains that can “read” and “edit” the histone modifications. 
Thus, there are “reader” domains, such as bromodomains, chromodomains or PHD 
fingers, which can differentiate and selectively recognize certain PTMs on histone tails 
[41-44]. “Editors” are represented by different transferases, demethylases, 
deacetylases, etc. domains, which are able to transfer a modification to a histone tail 
residue or remove it [45-48]. An example of methyltransferases is the SET-domain 
family that transfers methyl groups to lysines of histone and non-histone proteins [49-
52]. Domains which are able to transfer or remove acetyl groups from histones are 
called histone acetyltransferses (HATs) and histone deacetylases (HADs) [53-55]. 
These “reader” and “editor” domains usually work in combinatorial mode, where a 
“reader” domain recognizes a certain PTM mark and brings a functional “editor” to 
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alter the state of a histone protein allowing regulation of associated genes. Composition 
and presence of such “readers” and “editors” is specific to a protein family and 
conditions a protein’s function [36,56-58]. 
 
Figure 2. Nucleosome structure and post-translational modification of N and C-
terminal histone tails. H2A, H2B, H3 and H4 – core histones; H1 – linker histone; Ac 
– acetylation, Me – methylation, Ph – phosphorylation, Ub – ubiquitination 
modifications. Figure from Tollervey et al. [40]. 
1.4 PTM “readers”: structural aspects, function and selectivity 
For a histone modifying enzyme to function with a certain level of precision, its 
“reader” domain needs to be selective to a specific histone tail modification, to be able 
to position the protein at the required location. The specificity of the interaction arises 
from the structure of the “reader” and its mechanisms of interaction and recognition of 
specific PTM. The examples of such domains are Bromodomains, Chromodomains, 
PHD fingers and CW. 
1.4.1 Bromodomains 
Bromodomains mediate recruitment of enzymes, factors or associated chromatin 
remodeling complexes by the recognition of acetylation modifications. They are found 
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in many multidomain proteins which constitute chromatin remodeling complexes and 
transcriptional regulators. Bromodomain containing proteins are represented in 
humans by eight protein families with different functions [59,60]. Among them, for 
example, is the ASH1L methyltransferase which acts as a transcription factor [48].  
p300 and CREBBP are acetyltransferases which are able to modify histone proteins 
and regulate chromatin structure, and play a role in DNA replication, damage signaling 
and repair processes [61,62]. BRD1, BRD2, BRD3, BRD4, BRDT are examples of 
transcription factors which recruit transcription elongation complexes, and also 
associated with assembling and mediating the SWI/SNF chromatin remodeling 
complexes [59]. 
All bromodomains share conserved structural organization of four α-helixes (Figure 
3A), designates as αA, αB, αC and αZ, linked by loops with various lengths and amino 
acid sequences. The loop between αZ and αA helixes is called the ZA-loop and the 
loop between αB and αC is called the BC-loop. Structural studies explain how 
bromodomains are able to recognize specific acetylation marks. A hydrophobic binding 
pocket is formed by the extension of the ZA and BC loops of the cavity formed by four 
α-helixes. The acetylated side chain of lysine residue of a peptide is inserted into the 
binding pocket, forming an extensive interaction network of hydrogen bonds and Van 
der Waals interaction [46,48,59,63-65]. 
1.4.2 Chromodomains 
Chromodomains were the first methylated histones recognition domains to be 
characterized and are also constituents of multidomain proteins with particular 
functions and domain organization. Chromodomains are shared among different 
protein families with functions related to activation or silencing of gene expression. 
Proteins with these domains can be divided into three subclasses: proteins which have 
chromodomains at their N-terminal and C-terminal chromo shadow domains; proteins 




Heterochromatin protein 1 (HP1) is an example of the first of the three classes. HP1 
was originally characterized in Drosophila and then identified in animals and yeasts 
but not in plants. Proteins in the HP1 family have a chromodomain at their N-terminal 
and a C-terminal chromo shadow domain, connected by a linker region of variable 
length [68].  HP1 proteins are able to recognize H3K9 methylated marks by its 
chromodomains, and are involved in gene silencing and organization of 
heterochromatin [43,69]. 
The chromodomain of Polycomb proteins has specificity to methylation marks at 
H3K27 [70]. The Polycomb group proteins constitute polycomb repressive complexes 
(PRC1 and PRC2), which are involved in gene silencing and regulation of high-order 
chromatin organization during cell differentiation and hematopoiesis [71-73]. 
In contrast, MOF and MSL3 are the proteins of the male-specific lethal (MSL) group 
of proteins and are able to bind non-coding roX2 RNA by their chromodomains, upon 
formation of a X-chromosome-associated dosage compensation complex (DCC). In 
Drosophila, to compensate for the lack of the second X chromosome in males, the DCC 
is functioning to increase transcription from the male X chromosome [74-76].  
The conserved structure of the chromodomains is characterized by formation of tree-
stranded anti-parallel β-sheets and a C-terminal α-helix (Figure 3B). Binding 
mechanism for these domains is conditioned by the formation of an aromatic binding 
pocket in which a methylated lysine residue is inserted. The rest of the peptide sequence 
binds as a β-strand in the conserved groove and promotes the formation of so-called β-
sandwich structure. In contrast to acetylation, methylation modification does not 
neutralize the positive charge of the modified residue. This positive charge on 






Figure 3. Representative structures of: A –  Bromodomain (bromodomain of PCAF 
p300/CBP-associated factor in complex with H3K9ac, PDB: 2RNW [79]); B – 
Chromodomain  (HP1 chromodomain in complex with H3K9me1, PDB: 1KNE [80];  
and C – PHD-finger (BPTF PHD finger in complex with H3K4me3, PDB: 2FUU [81]). 
Residues in the binding pockets are highlighted in blue; bound peptide colored in 
orange with residue that is being recognized colored in red. 
 
1.4.3 PHD fingers 
Plant homeodomain (PHD) fingers are another well-studied example of epigenetic 
readers with selectivity towards methylated and unmodified H3 histone. Just like the 
other “reader” domains, PHD fingers are shared among different protein families with 
different functions related to activation or repression of transcription. PHD fingers of 
ING protein family selectively recognize H3K4me3 modification, bringing 
acetyltransferase or deacetylase domains to modify chromatin [41,42,82,83].  
PHD fingers are found not only in proteins with certain catalytic activities, but also can 
act as scaffold proteins for macromolecular chromatin remodeling complexes. The 
CHD4 ATPase is a subunit of the NURD nucleosome remodeling complex. CHD4 has 
two PHD fingers, and one of them was shown to recognize H3K9ac and H3K9me 
modifications [84,85]. The BPTF transcription factor is a subunit of the NURF 
nucleosome remodeling factor, functioning by H3K4me3 recognition by its PHD finger 
[81]. The DPF3b protein functions in association with the BAF chromatin remodeling 
complex and was shown to specifically recognize acetylation modifications of H3 
histones at 14th lysine (H3K14ac) [86-88]. 
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PHD fingers show low sequence similarity but have a highly conserved fold. Their 
structure is maintained by two Zn2+ ions coordinated by conserved cysteine residues. 
Two anti-parallel β-sheets in the fold of the domains scaffold the aromatic binding 
pocket and promote interaction with histone peptides (Figure 3C). Mechanism of 
recognition and specificity is shaped by conserved structural features, forming binding 
sites. The side chain of a methylated lysine residue of a histone peptide is inserted in 
the aromatic binding pocket formed by aromatic sidechains. The aromatic binding cage 
might be formed by two to four residues which promote the formation of π-cation, 
hydrophobic and Van der Waals interactions. Bound peptides form an additional anti-
parallel β-strand by β-augmentation. In contrast, PHD finger domains, which are able 
to recognize unmodified H3K4 peptides, lack the aromatic binding pocket. Interaction 
with unmodified peptides is mediated by a cluster of acidic residues, forming hydrogen 
bonds and salt bridges with the inserted side chain of a lysine residue. In the case of a 
binding pocket, which is selective to acetylation modification (H3K14ac), it also 
consists of aromatic and charged residues [81,83-86,88]. 
1.4.4 CW domains 
The CW domain family was initially described by Perry and Zhao, 2003 as a four-
cysteine zinc-finger motif, and shown to be shared among vertebrates, vertebrate-
infecting parasites and higher plants. Like Bromodomains, Chromodomains and the 
PHD-fingers, the CW appears in different protein families. The name of the domain is 
derived from its conserved cysteines and tryptophans at specific positions. 
Proteins that contain the CW domain were identified to be involved in epigenetic 
regulation and chromatin remodeling, where CW selectively recognizes methylation 
modifications at the histone H3 lysine 4 (Figure 4A). Among them, for example, is 
plant ASHH2 methyltransferase, which regulates gene expression by Histone H3 
trimethylation at Lys-36 (H3K36me3) [89,90]. ZmMBD101 protein, which belongs to 
the MBD protein family, is involved in maintenance of the repressed state of the 
Mutator genes and protects plant genomes from harmful mutations induced by 
transposons. The function of the CW domain in this context is yet unclear [91]. The 
CW domain of the MORC3 family of ATPase chromatin remodelers recruits the 
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MORC3 to the chromatin and negatively regulates ATPase activity [92,93]. CW is 
present in the ZCWPW1 and ZCWPW2 PWWP-domain containing proteins which can 
recognize H3K4me3 and H4K20 methylation marks, but the function of these proteins 
is yet to be understood [94-96]. CW containing LSD2/AOF1/KDM1B protein, which 
belongs to the amine oxidase family, functions as transcriptional co-repressor by 
demethylation of mono- and dimethyl H3K4 marks. The CW domain in its context 
appears to be inactive as it was shown to be sterically inaccessible and not able to bind 
histone tails, but it still contributes to the overall structural stability and regulates the 
activity of the enzyme and its association with mitotic chromosomes [96-99]. 
Sequence alignment of CW from different protein families shows a high degree of 
variability with only a few conserved regions (Figure 4B). Structure of the domain is 
characterized by the formation of two antiparallel β-sheets, which scaffolds a π-
electron based binding pocket formed by two conserved tryptophan side chains. 
Cysteines coordinate a Zn2+ ion in the core of the domain, maintaining its fold. 
Sequence variability is translated into disordered loops that differ for CW homologs 
(Figure 4C) [90,95,100].  




Figure 4. Comparison of CW domain containing proteins and CW structures. A – 
domain organization of CW containing proteins: Arabidopsis ASHH2, Human 
MORC3 and ZCWPW1; B – sequence alignment of different CW domains. Structural 
features are indicated, C-terminal region is variable; C – representative structures of 
CW-domains from ASHH2, MORC3, ZCWPW1, ZCWPW2 and LSD2 proteins. 
Sequence alignment was prepared using Jalview software with ClustalO algorithm with 
default parameters, Clustalx coloring scheme was used. Graphics were prepared using 
UCSF Chimera software and pdb files of domains in unbound state.   
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1.5 Selectivity of CW domains 
CW domains from different protein families show different preference towards 
methylated states of the 4th lysine of the H3 histone. Even though CW can interact with 
mono- di- and trimethylation modifications, CW domain from ASHH2 
methyltransferase was shown to be more specific to H3K4me1 [90,101], and CW from 
MORC3, ZCWPW1, ZCWPW2 proteins bind stronger to H3K4me3 mark 
[92,93,95,96]. 
The mechanism of selective differentiation of a histone modification for various CW 
specificity is not well understood. Comparison of known structures of the domains 
from different protein families shows structural differences which might shape and 
regulate specificity of the domains.  Variable C-terminal regions upstream of the CW 
domain motif might be involved in regulation of specificity towards ligand of different 
methylation states (Figure 4B, C). The C-terminal end of ZCWPW1 posses a 
tryptophan residue (Trp303). It finalizes the binding pocket when the ligand is bound 
and conditions affinity [95]. Its homolog ZCWPW2 has a phenylalanine residue at the 
same position (Phe78), which serves a similar function and possibly contributes to 
selectivity between methylation states of H3K4 [96]. CW domain from MORC3 
proteins has glutamic acid (Glu453) at this region, which also finalizes the binding 
pocket upon interaction with a ligand and contributes to binding to H3K4 di- and 
trimethylated ligands [92,93,96]. CW domains of ASHH2 and LSD2 (other names are 
AOF1 and KDM1B) are examples of helical structures at the C-terminal region. For 
LSD2, it was shown by Zhang et al., 2013 that the CW domain is lacking any binding 
activity due to various structural hindrances caused by the neighboring SWIRM and 
C4H2C2 zinc finger domains, and by electrostatic repulsion of the positively charged 
histone tail [97]. In ASHH2, the α1-helix is located above the tryptophan binding 
pocket (Figure 4C). Hoppmann et al., 2011 have shown that removal of this helix 
abolishes the binding activity of the domain [90]. Later Liu and Huang, 2018 have 
reported Ile915, Asn916 and Leu919 residues from this helix to be the key in 
determining specificity towards the monomethylated state [101].  
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1.6 ASHH2 methyltransferase of Arabidopsis thaliana 
A gene encoding methyltransferase ASHH2 (other names are SDG8, EFS and CCR1) 
was characterized in a small flowering plant Arabidopsis thaliana, with non-redundant 
role associated with regulation of flowering time, branching, hormone response and 
other, controlling expression of more than 1000 genes [89,90,102-104]. The primary 
function of the enzyme is considered to be transferring di- and trimethylation 
modifications to H3K36 residue, a modification which is associated with increased 
level of gene expression [89]. The enzyme is 1759 amino acids long and consists of the 
CW domain followed by AWS, SET and Post-SET domains (Figure 4A). 
Methyltransferase activity is pertained to the SET-domain. ASHH2 recognizes the 
H3K4me1 modifications by CW. This interaction brings the SET-domain to the 
vicinity of the histone it acts upon and allows modification of H3K36 residue, which 
leads to a subsequent increase in expression of associated genes [90]. Loss-of-function 
mutation in ASHH2 gene results in repressed expression of genes regulating flowering 
time and plant development, which correlates with a general reduction of 
H3K36me2/me3 chromatin modifications [102,105,106]. Function of AWS and Post-
SET domains is not yet clear, but they can, conceivably, function as autoinhibitors of 
the methyltransferase activity of SET-domains and play a role in interaction with the 
H3 histone, regulating the positioning of the SET [107-109].  
1.7 Theoretical models of protein binding 
A protein’s function is linked to its interactions with other molecules. This, in turn, is 
related to its fold and dynamical properties [110,111]. There are two extreme cases 
where a protein exists as a very rigid structure with a well-defined fold, and proteins 
that are missing any folding, the so-called intrinsically disordered proteins [112]. 
The first and probably the most intuitive model for protein binding is the one proposed 
by E. Fischer already in 1894, where he proposed that proteins and their ligands fit 
each other in a lock-and-key manner [113]. This concept implicitly assumes relatively 
rigid bodies interacting with each other. However, since protein function and its 
interaction with binding partner emerges from the fold of the protein, which is never 
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entirely rigid and often is highly fluctuating, it is useful to look at the binding models 
from a folding funnels perspective, as suggested by Ruth Nussinov research group 
[112,114].  
Folding funnels represent the energy landscape as a function of conformational 
properties of a protein folding [115]. A population of denatured conformations of a 
protein follows the surface of a folding funnel down to the bottom to obtain a fold with 
minimal energy. Depending on conditions, folding can follow different paths, 
displaying various intermediate conformations. The shape of the bottom of a folding 
funnel determines the flexibility and dynamics of the protein fold. Thus, for proteins 
with a rigid structure, folding funnel will have a deep, well-defined minimum (Figure 
5A), while for flexible proteins it will be characterized by presence of several minima 
or a broad continuous well, which corresponds to presence of an ensemble of 
conformations (Figure 5B), and the more flexible a protein is, the higher is the number 
of the conformers it can obtain [114,116]. 
Interaction of a protein with a rigid structure with its also rigid ligand is best described 
by the “lock-and-key” interaction model (Figure 5C). Existing as one stable 
conformation, such protein exhibits high specificity to its ligand with minor structural 
changes after binding [114,116]. Wedemayer et al., 1997 explored the interaction 
mechanism of a matured antibody in comparison with its corresponding germline 
antibody [117]. Analysis of X-ray crystal structures of antibodies in their free states 
and in complex with a hapten antigen showed small conformational changes in matured 
antibodies upon binding, following the “lock-and-key” type of rigid interaction. On the 
other hand, structural changes in germline antibodies were more significant after 
complexation with the hapten antigen, indicating that the interaction corresponds more 
to a regime where binding stabilizes new conformations in the complex.  
Binding of flexible proteins, which exist as an ensemble of conformations, is better 
described by the “conformational selection” and “induced fit” models. In the 
“conformational selection” a ligand “chooses” the most favorable conformation of a 
protein to form a stable complex. And, in the “induced fit” model of binding, the ligand 
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will induce structural changes in the protein to adopt a conformation that will stabilize 
the complex. Figure 5C depicts scenarios for these interaction models. These two 
processes usually occur together, and the predominance of “conformational selection” 
or “induced fit” is kinetically regulated, meaning that it depends on how fast a protein 
exchanges between its conformations, and how fast those conformations can accept a 
ligand in the binding centers [118,119]. The flexible nature of such proteins allows 
them to interact with several ligands or other proteins. An example of these is p53, 
which has numerous intrinsically disordered regions crucial for its functions. The 
unstructured N-terminal region contains functional transactivation domains that form 
α-helical structures upon binding to its ligand. The C-terminal end has regions 
responsible for oligomerization and tetramerization, and a regulatory region that can 










Figure 5. Schematic depiction of landscapes around the bottom of folding funnels and 
protein binding models. A – funnel bottom with a well-defined energy minimum; 
corresponds to a protein with a stable conformation and lock-and-key binding model. 
B – funnel with a rugged bottom and low energy barriers between the minima; 
corresponds to a flexible protein existing as ensemble of conformations and 
conformational selection binding model. C – schematic scenarios of the interaction 
models: Lock-and-key, where a rigid protein (red dot, ●) binds its ligand (yellow dot, 
●) as the interacting surfaces match; Induced fit, where a ligand binds present 
conformation of a protein and induces conformational changes of the partner; 
Conformational selection, where a ligand binds one of the present fluctuating 
conformations without inducing further conformational changes; Conformational 
selection and induced fit, where a ligand binds one of the present fluctuating 
conformations of a protein and induce conformational changes in the partner. Figure 
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1.8 Conformational selection in structural biology. Relevance 
and methods 
All biological processes and their regulation are based on mechanisms of molecular 
recognition between a ligand and its target, associated with conformational changes of 
the interacting partners [119,124,125]. Understanding of these mechanisms in terms of 
structure, energy and kinetics of interaction is crucial for efficient drugs and 
therapeutics development, engineering of new enzymes, as well as answering 
fundamental questions in biology. Different models proposed to characterize these 
processes were reviewed earlier in the text in Section 1.7. For this purpose, purely static 
models of molecular interaction were not satisfactory, and attention was shifted from 
Fisher’s lock-and-key model towards dynamic models of binding, which try to account 
for conformational rearrangement of interacting receptor and ligand [126]. 
Combination of methods like nuclear magnetic resonance (NMR) spectroscopy, 
molecular dynamic simulations and molecular docking, biophysical methods like 
isothermal titration calorimetry (ITC) and fluorescence spectroscopy allows deep 
characterization of the interaction processes taking into account dynamic 
conformational variations [126-128]. 
The theoretical framework of conformational selection has contributed to advances in 
both technology and fundamental biology including gene regulation. For example, the 
presence of intrinsically disordered regions in transcription factors introduces another 
level of conformational flexibility that is involved in regulation of selectivity 
mechanisms in competitive binding [129,130]. Conceptualization of these mechanisms 
enabled the design of transcription factors which specifically target a given regulatory-
DNA sequence of a gene, bringing the effector domain to modulate transcription 
[131,132]. It also allowed a search for transcription factor inhibitors that potentially 
could be used as new cancer therapeutics [133]. The proposed involvement of 
conformational selection in gene regulation and the presence of mobile loops in CW 
and its flanking regions in the ASHH2 protein suggests that the action of CW may 
require molecular insights other than those provided by lock-and-key type of 
mechanisms. 
1 9  
 
1.8.1 Molecular interaction and dynamics by Nuclear Magnetic Resonance 
spectroscopy 
One of the most useful methods for studying the interaction mechanisms is Nuclear 
Magnetic Resonance (NMR) spectroscopy. NMR provides a vast set of applications 
that allow detection of changes in NMR parameters of the ligand or the target molecule, 
such as chemical shifts, relaxation rates, diffusion properties and intermolecular cross-
relaxation [134-137]. A widely used method is the 1H-15N heteronuclear single 
quantum coherence (HSQC) spectrometry of 15N isotopically labeled proteins in the 
absence and presence of a ligand. The method enables monitoring of the changes in 
chemical shifts of the target upon ligand binding. This information can be used for 
mapping of binding sites and identification of the residues that are directly or indirectly 
involved in the interaction [138,139].  
Under a complexation of a ligand with its target molecule, the overall dynamic 
properties of flexible molecules tumbling in solution are expected to change. These 
changes can be detected and quantified by NMR methods which allow measuring 
relaxation rates, relaxation dispersion or exchange processes, which are directly 
affected by protein dynamics. The methods are sensitive over a broad time scale of 
motion (ps to s) Figure 6 [127,140-143].  
In later years, the determination of relaxation rates of longitudinal magnetization (T1 
and R1), transverse magnetization (T2 and R2) and relaxation of heteronuclear spin-spin 
magnetization of Nuclear Overhauser Effects (hNOEs) has been developed into a 
standardized tool for experimental assessment of different modes of internal protein 
dynamics at the ps-to-ns time scale. R1 and R2 parameters characterize the overall 
tumbling and the local flexibility of a protein backbone, and hNOE parameters describe 
the motion of the NH-bond vector [144-147].  
For deeper characterization of protein dynamics, the internal protein motions need to 
be separated from its global tumbling. For this purpose, application of a so-called 
model-free analysis was proposed by Lipari and Szabo in 1982. In contrast to 
alternative approaches being used at the time, the model-free approach does not 
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explicitly model individual atoms in the protein being examined [148]. Rather, it 
interprets relaxation data, assuming statistical independence of the global motion of a 
protein and its internal motion [149,150]. By using the T1, T2 and hNOE data it allows 
characterization and analysis of spatial restrictions of the motion of intermolecular 
vectors. These motions are generalized by the order parameter S2, which indicates the 
relative contribution to the relaxation from the overall molecular motion and from 
additional local motion. The S2 parameter lies in the 0 to 1 range, where 1 corresponds 
to no local motion and 0 represents a fully flexible protein. It also allows 
characterization of the oscillation time for the complex motion of a given residue, 
described by the effective internal correlation time parameter τe, and calculation of 
conformational exchange contribution, Rex, to the observed transverse relaxation rate 
R2, which characterizes the rate of transition between two distinct states of a residue 
[145,149-153]. 
 
Figure 6. Time scale of protein dynamic processes and NMR methods used to study 
them. (PRE – paramagnetic relaxation enhancement; H/D exchange – 
hydrogen/deuterium exchange; ZZ-exchange also called exchange spectroscopy 
EXSY). Figure prepared based on Li et al. and Kleckner et al. [143,154] 
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While relaxation measurements with subsequent model-free analysis are used for 
assessment of the dynamics at ps-to-ns time scale, the relaxation dispersion (RD) 
method can provide information about the processes at µs-to-ms time window. This 
timescale includes protein secondary structure changes, loop motions and side chains 
reorientation, related to ligand binding and folding [155,156]. The method analyzes the 
peak broadening caused by conformational exchange. Named after inventors Carr 
Purcell Meiboom Gill (CPMG), this pulse sequence allows to quench the relaxation 
due to exchange and then calculate effective relaxation rates R2eff [157,158]. The 
dispersion profile of CPMG experiment can be fitted to dynamical models (no 
exchange, slow exchange and fast exchange), which parameterize the exchange 
between two conformational states in terms of rate, kex, populations of states and 
chemical shift differences between states, δω.  
In summary, NMR provides a very versatile set of methods for exploring protein 
dynamics. Depending on the particular techniques being employed, NMR allows 
characterization of the dynamics underlying allostery, conformational fluctuations and 
mechanisms of conformational selection [154,158-161], mechanisms of protein folding 
[162], oligomerization [163], and enzymatic mechanisms [164-166]. It was also 
utilized for structural probing of nucleic acids [167-170]. 
1.8.2 Molecular dynamics by computer simulation 
Computation methods such as molecular dynamic (MD) simulations can contribute to 
and provide information on the understanding of molecular flexibility and interaction 
mechanism, especially when experimental data is limited [171,172]. Molecular 
dynamic simulations and NMR data together can shed the light on internal motion of a 
protein, including the dynamics of the backbone and side chains, and characterize 
protein folding. For interactions, MD simulations can be used to explore 
conformational responses upon binding, such as the induction of secondary structure, 
stabilization or release of loops as well as determining intermolecular contacts between 
ligand and target protein [173-176]. Another advantage of molecular dynamics 
simulation is the possibility of modeling the systems at different temperatures to access 
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how the solvent affects the internal motion of proteins and predict the interaction 
mechanism [177-180]. 
At the beginning of an MD simulation, a system is initialized by creating a state with 
the defined types and positions of the particles. Then interaction potentials, referred to 
as force fields or potential energy functions, are introduced to the system by using 
mathematical equations that describe the interaction between the particles. For 
proteins, these force fields express covalent (bond length and dihedral angles) and non-
covalent interactions (electrostatics, van der Waals, polar, etc) [181]. Among the most 
popular force field programs are AMBER and CHARMM, which are designed as a 
collection of codes (scripts) which work together [182-184]. The next step includes 
computation of forces acting on each particle of the system, based on their interaction 
potentials. By solving classical equations of motion, new position and velocity of the 
particles based on the force exerted on each particle is then calculated. After that, the 
system is adjusted to control the thermodynamics parameters such as temperature and 
pressure. By repeating this algorithm for a required number of cycles, the trajectory of 
the particles can be computed, and the behavior of the whole system can be tracked and 
characterized at the atomic level of detail [128,177,181,185]. 
1.8.3 Isothermal Titration Calorimetry 
A system of interacting molecules is associated with changes in global thermodynamic 
parameters. Isothermal titration calorimetry (ITC) allows characterization of these 
parameters and quantification of driving forces that lead interaction in a certain 
direction towards equilibrium. This information can help to understand the 
thermodynamical basis of binding mechanisms and provide binding constants [186]. 
By comparison within a set of related interactions it can also answer questions of the 
specificity of the interacting molecules [186,187]. Direct measurement by ITC of the 
heat released or consumed by the interacting system allows calculation of change in 
free energy of the system ∆G, which is connected to equilibrium binding constant Ka; 
change in enthalpy ∆H, which is the heat associated with formation or breaking of non-
covalent bonds during formation of the complex; and change in entropic state ∆S, 
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which characterize the change in degree of freedom of the system [188-191]. 
Interdependence of these parameters is expressed in the next equations: ∆ = − ����  (1) ∆ = ∆ − ∆   (2) 
Where R is the universal gas constant (8.314 J/mol∙K), T is the temperature in degrees 
Kelvin, Ka is the binding constant (M-1), ∆G is the Gibbs free energy (J/mol), ∆H is the 
enthalpy term (J/mol), and ∆S is the entropy term (J/mol∙K) [187]. 
Enthalpy and entropy are the two components of the overall energy of the system and 
the balance of enthalpy-entropy contribution will define the mode of interaction. Thus, 
lock-and-key type of interaction is dominated by gain in solvent entropy, induced fit 
mechanism is enthalpy driven, and conformational selection is characterized by 
sequential solvent entropy gain and enthalpy decrease of the system, that dives the 
conformational adjustment [192-195]. 
1.8.4 Fluorescence spectroscopy 
Structural characterization of a protein fold and its complex with a ligand can be 
supplemented with information that addresses questions of stability. Monitoring the 
fold of a protein as a function of e.g. ligand binding, temperature or denaturants is a 
well-established method of gaining such information [196-199]. Fluorescence 
spectroscopy exploits the properties of aromatic amino acids to emit light after 
excitation by UV-light. Tryptophan is the most popular probe as it has the highest 
absorptivity [200,201]. The emission peak (λmax) of tryptophan is sensitive to its 
immediate environment that depends on solvent accessibility and protein fold. Shorter 
wavelengths of λmax is associated with thryptophans buried inside the structure, while 
tryptophans that are exposed to the polar environment of the solvent are characterized 
by longer λmax [197]. Recording emission spectra of a folded protein under a subsequent 
gradual increase in temperature (or increase of concentration of a denaturing 
compound) until it unfolds, the change in λmax can be monitored [202,203]. By 
analyzing this data using sigmoidal curve fitting, a conclusion of protein fold stability 
can be made, expressed as the melting temperature Tm. Adding interacting partners to 
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the system can provide information on the change in stability of the formed complexes 
[200,204,205]. By the same principle, the changes in emission spectra can be used to 
monitor protein association with ligands and conformational transitions of a protein in 
titration series with a gradual increase in concentration of the added interaction partner 
[198,199,206]. 
1.8.5 Size measurements of proteins and their complexes in solution 
In contrast to detailed characterization of molecular interaction in terms of structure, 
thermodynamics or different exchange constants, estimation of molecular qualities like 
the size of a molecule or a complex is a comparatively simple and intuitively 
interpretable information [207]. The changes of the size and shape of a protein and 
associated with them hydrodynamic coefficients can be used to address conformational 
variations, folding and aggregation processes and interaction with ligands [208-211]. 
There are many ways of determining the sizes of proteins in solution, including size 
exclusion chromatography (SEC), light scattering techniques and NMR diffusion.  
Size exclusion chromatography enables separation of molecules based on their 
excluded volume and is able to separate monomers, dimers, aggregates or molecular 
complexes. Traveling through the SEC column, molecules with a bigger size will exit 
faster than smaller ones, which are retained longer within the maze-like structure of the 
matrix [212,213]. Techniques like static light scattering (SLS), multi-angle light 
scattering (MALS) and dynamic light scattering (DLS) utilize properties of molecules 
in a solution to scatter light. Estimation of size, molecular weight and diffusion 
properties can be achieved by measuring how much light was scattered, and this 
directly correlates with the dimensions and motions of a molecule [211,214,215]. Size 
exclusion chromatography and multi-angle light scattering (MALS) can be coupled 
together when the flow from SEC is going through a MALS detector that measures 
time-average intensity and proportion of light scattered by an analyte at multiple angles 
in relation to the incident laser beam. Analysis of the variations in the scattered light 
allows determination of the size of the molecules and molecular complexes expressed 
as radius of gyration, Rg [207,214,216,217]. 
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Another useful method is NMR diffusion. The method allows measurement of 
diffusion coefficients, which are directly related to the protein size (through the Stokes-
Einstein equation, equation 3). NMR diffusion experiments are set up as pulsed-field 
gradient (PFG) pulse sequence with varying gradient strengths. The first gradient pulse, 
which defocus the signals, is followed by a delay at which the molecules are let to 
diffuse. After this time interval, a second gradient pulse with the same magnitude and 
duration, but with the opposite effective sign is applied to refocus the signals. The 
resulting intensity of the signal is dependent on the pulse strength and duration, delay 
time and diffusion coefficient D of the studied molecules. Thus, for the molecules that 
move quickly, the signal will not be refocused and will result in low intensity. For 
larger slow moving molecules, the refocusing regains the signal [208,218,219]. The 
data of a diffusion experiment is a recording of a set of 1D spectra, each with a different 
gradient strength or diffusion delays. Processing of the data will result in a 2D map 
relating chemical shifts to the diffusion coefficient. By detecting the changes of the 
diffusion coefficient, the method enables characterization of folding and aggregation 
processes, interaction with ligands, and separation and identification of individual 
compounds in complex mixtures [208,210,220,221]. 
� = ���6���   (3) 
In equation 3, D is the diffusion coefficient, kB is the Boltzmann constant, η is the 
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2. AIMS OF THE STUDY 
The overall objective of the work was to elucidate and understand the structural and 
biophysical requirements underlying the specificity of the ASHH2 CW domain 
interacting with histone tails with variable methylation states. The aims are 1) to 
determine the structure, dynamics, and thermodynamical binding parameters of the 
CW-H3K4me1 complex, and 2) to investigate the role of structural features like the 
α1-helix, unstructured regions and geometry of the binding pocket with respect to the 
domain’s binding preferences, conformational stability and selection mechanism. 
Initially, there was also an aim to characterize the function of CW in the context of 
ASHH2 mini-enzyme construct, but this attempt was not achieved as we failed to 
establish an expression system for the enzyme production. 
2.1 ASHH2 CW-H3K4me1 complex structure 
Since publishing of the ASHH2 CW domain structure in its free state, the mechanism 
of CW binding and selectivity to the H3K4me1 peptide remained unclear. Analysis of 
available CW domain structures in complex with corresponding peptides suggests a 
common mechanism of interaction, with variable elements specific to particular CW 
subtypes. Liu and Huang, 2018 reported a crystal structure of the ASHH2 CW domain 
in complex with H3K4me1 peptide, highlighting important features and aspects of 
histone tail recognition, such as involvement of residues from α1-helix and the η1-loop 
region. The binding mechanism was discussed primarily in terms of lock-and-key 
interaction model. The published structure is not without limitations, as to solve it, a 
mutant E917A was used in order to achieve crystallization, and the domain was also 
truncated after residue I921, which is close to the functionally important 1-helix.  
The objectives of the first part were to solve the NMR structure of ASHH2 CW domain 
in complex with H3K4me1 peptide, avoiding the limitations of the previously 
published structure, supplementing with analysis of the domain’s internal dynamics to 
provide deeper and more detailed understanding of the contribution of the disordered 
regions in the binding mechanism.  
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2.2 Biophysical aspects of ligand binding and specificity 
In the second part we aimed to analyze the primary determinants of interaction and 
understand how different structural features shape and affect interaction forces. 
Functionality of the unique to the ASHH2 subtype α1-helix, geometry of the binding 
pocket, and the role of disordered regions of the domain are of particular interest. With 
thermodynamical and structural characterization of the wild type interaction with 
histone mimicking peptides, supplemented with mutation studies, we aimed to 
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3. METHODOLOGY 
Objectives formulated in Section 2 were approached by a combination of different 
NMR methods to characterize mechanism of interaction of ASHH2 CW domain 
complex structurally and study its dynamics. Molecular dynamics simulation (MD) 
was employed to make comparison between solved structures of ASHH2 CW, focusing 
on flexibility. Furthermore, methods of biophysical characterization (ITC, tryptophan 
fluorescence spectroscopy, NMR diffusion measurements) allowed to asses 
thermodynamic parameters of CW-ligang interactions, and physical properties like size 
and stability. An overview of the methods and their principles is given in section 1.8 
and in Figure 7, and in each paper of the thesis as indicated at the end of each 
subsection. 
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Figure 7. Overview of the methodological approach of the thesis. 
3.1 Materials 
The Histone H3 tail mimicking peptides were synthetized by Lifetein and had 95% 
purity as assessed by mass spectrometry. For some NMR experiments the peptides also 
were selectively 15N and 13C labled in positions A1, A7, R2 and R8. A mutated T6A 
monomethylated peptide was also used as a control. An additional tyrosine was 
introduced to the peptide sequences for concentration determination by absorption at 
280 nm (NanoDrop), and an extinction coefficient of 1490 M-1 cm-1 was used. The 
peptide sequences are summarized in Table 1. D2O, 15N enriched (99%) NH4Cl and 13C 
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enriched (99%) glucose were purchased from Cambridge Isotopes, and SVCP-Super-
3-103.5 NMR tubes were acquired from Norell. Unless otherwise specified, samples 
were buffered by the T7 solution (25 mM Tris-HCl pH 7.0, 150 mM NaCl, 1mM 
TCEP) or NMR buffer (20 mM phosphate, pH 6.4, 50 mM NaCl, 1 mM DTT). For 
protein purification TZNKβT buffer (50 mM Tris-HCl, pH 8.5, 12 mM NaCl, 100 μM 
ZnAc2, 150 mM KCl, 2 mM MgCl, 10 mM β-mercaptoethanol) was used. Buffer 
components were acquired from Sigma-Aldrich.  
More details on the materials description can be found in the Material and Methods 
sections of all three papers, under subheadings “Materials and experiments” in Paper 
I, “Materials” in Paper II, and “Materials” in Paper III. 






















X* indicates isotope-labeled site, where X is the amino acid. 
3.2 In Silico analysis 
Initial analysis of CW domains included sequence alignment using Jalview software 
[222] with Clustal O algorithm with default parameters. Analysis and comparison of 
CW structures was performed with UCSF Chimera [223], PyMOL and POSA web tool 
[224]. 
More details on the method description can be found in the Material and Methods 
section under subheading “Analysis of known structures” in Paper III. 
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3.3 Cloning of CW constructs, site-directed mutagenesis 
After in silico analysis, in the attempt to generate a construct suitable for crystallization, 
several constructs with various length of N- and C-terminal ends were produced by 
ligation independent cloning into KpnI/SacI restriction sites of pET-49b vector 
(Novagen). Figure 8A presents used primers maped on CW sequence. The constructs 
fused to an N-terminal GST-tag were subsequently cloned into pSXG vector (R. 
Aasland, V. De Marco, V. Christodoulou and S. J. Gamblin, unpublished). Between 
CW and GST-tag there was a thrombin cleavage site, and this design would allow 
purification and cleavage of the constructs on the column. The most successful 
constructs, in terms of ligand binding, were CW33, CW37 and CW42 (analysed by 
fluorescence spectroscopy). These constructs in complex with H3K4me1 ligand were 
used for a crystallization attempt. The crystallization efforts failed, and structural 
analysis proceed using NMR. The CW42-construct was chosen for further studies as it 
was expressing with high yields and had affinity comparable to previously studied CWs 
[90].  
The CW42 construct was also subjected to site directed mutagenesis using PCR with 
different pairs of primers carrying a mutation. These were mutations in the α1-helix 
(I915A and L919A), η1 and η3 loops (D886A, S907P, S907G and Q908E), C-terminal 
coil (Q923A) and loop connecting the β-sheets (CW-M3loop and CW-Z1loop). 
Position of mutations mapped on the structure are shown in Figure 8B. 
Generated plasmids were then used to transform chemicompetent cells. Cells were 
plated on agar-plates supplemented with ampicillin for the selection of successful 
transformants. Bacterial cultures grown from individual colonies were then used to 
prepare mini-preps of plasmids. The nucleotide sequences of the plasmids were 
verified by sequencing. 
In the course of the thesis work, expression and purification an ASHH2 mini-enzyme 
construct was attempted. This construct would allow studying possible effects of CW 
on the neighbouring methyltransferase SET domain. Two sequences were chosen for 
design: one contained all domains from ASHH2 (CW-AWS-SET-PostSET, residues 
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801-1290, denoted as SDG8) and methyltransferase domains only (AWS-SET-
PostSET, residues 938-1212, denoted as SDG8s). The sequences were cloned into 
pGEX-4T-1, pET His6 MBP TEV LIC (1M) and pET His6 SUMO TEV LIC (1S) 
vectors (Adgene) by ligation independent cloning. The constructs were fused with GST 
and His-tags for purification, and with MBP and SUMO-tags in an attempt to improve 
the solubility of the expression product [225,226]. Overview of the constructs is 
presented in Figure 8C. The resulted vectors were used to transform chemicompetent 
cells, and the obtained mini-prep plasmids were verified by sequencing.  
 
 
Figure 8. Design of CW constructs. A – primers used to generate CW constructs 
mapped on the CW sequence. CW42 was made with F4 and R2 primer pair. B – amino 
acids subjected to mutagenesis are shown on CW structure (highlighted in red). C – 
design of ASHH2 mini-enzyme constructs. 
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More details on the method description can be found in the Material and Methods 
sections of all three papers, under subheadings “Protein expression” in Paper I, 
“Materials” in Paper II, “Cloning of CW constructs, site-directed mutagenesis, protein 
expression and purificationand” in Paper II supplementary materials, and 
“Proteinexpression and purification” in Paper III. 
3.4 Protein expression and purification 
The BL21 bacterial strain for protein expression was transformed with the CW 
plasmids described above. Transformed bacteria were cultivated on 2xYTG media 
supplemented with ampicillin at 37 °C. During cultivation, the optical density 
(OD(A600)) of the media was monitored, and at the point when it was reaching 0.6 the 
expression was induced by adding IPTG to the media. After that, the culture was left 
to grow overnight at 18 °C. 
For production of labeled samples for NMR studies, the M9 minimal media was used. 
The media contained minimal required components for bacterial growth: trace 
elements, vitamins, nitrogen and carbon sources. Use of 15N ammonia sulphate and 13C 
glucose as the nitrogen and carbon sources allowed uniform labelling of the proteins. 
Culturing was done in a few steps: 2xYTG media mini-prep incubation overnight at 37 
°C, inoculation of M9 pre-culture (overnight incubation at 37 °C), transfer of pre-
culture to 1L M9 media and incubation until OD(A600) was reaching 0.6 with 
subsequent induction with IPTG. Overnight culturing was performed at 18 °C. 
The BL21 bacterial strain was also transformed with prepared mini-enzyme vectors 
and screened for optimal expression conditions. Cultures of transformed cells, picked 
from a single colony from agar plate, were grown at 16, 25 and 37 °C, and induced 
with IPTG after the OD was reaching 0.6. To monitor expression progress, the samples 
were taken from the media within 5 to 36 hours. This screening showed that none of 
the construct resulted in the expression of stable soluble constructs. 
After incubation the cells were harvested by centrifugation and resuspended in lysis 
buffer named TZNKβT, supplementing with EDTA-free protease inhibitor (Roche). 
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Resuspended cells were disrupted by sonication, and centrifuged to clear the lysate of 
cell debris. For affinity-based protein purification, Glutathione Sepharose 4B beads 
(GE Healthcare) were used. Before loading, the column was pre-equilibrated with 
TZNKβT buffer. GST-taggfed CW constructs were bound to the column by flushing 
the column or incubating it with the lysate supernatant. The loaded column was then 
washed with TZNKβT to remove all unbound materials. To cut the CW constructs off 
from the GST-tag, the column was incubated with biotinylated thrombin overnight. 
The cleaved protein was collected by flushing the column with TZNKβT buffer. 
Thrombin contained in this eluate was subsequently removed by incubation with 
Streptavidin Sepharose (GE Healthcare) followed by centrifugation. Purification steps 
were monitored by SDS-gel electrophoresis. The protein samples were purified further 
by size exclusion chromatography eluting with T7 or NMR buffer. Figure 9 shows an 
example of purification steps monitored by SDS-gel and SEC chromatogram of the 
final purified protein. The results are representative for the most mutants prepared in 
the project, and confirm in each case the purity and monomeric state of the constructs. 
The fractions containing purified protein were collected and concentrated using 
Amicon Centrifugal Filters with 3 kDa cut-off (Millipore).  
 
Figure 9. Monitoring of purification of CW constructs. A – SDS-gel (Lad – ladder, L 
– lysate, CL – cleared lysate after centrifugation, LP – lysed pellet after centrifugation, 
FT – flowtrough, W1 – first fraction of wash, W2 – last fraction of wash, E – elute). 
Red rectangles highlight position of GST-CW (1) and cleaved CW (2). B – SEC 
chromatogram, shows the elution peak of purified CW between 70-90 mL. 
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More details on the method description can be found in the Material and Methods 
sections of all three papers, under subheadings “Protein expression” and “Protein 
purification” in Paper I, “Materials” in Paper II, “Cloning of CW constructs, site-
directed mutagenesis, protein expression and purificationand” in Paper II 
supplementary materials, and “Proteinexpression and purification” in Paper III. 
3.5 NMR spectroscopy 
Sample preparation: Purified labled CW constructs were dissolved in NMR buffer 
containing 10% (v/v) of D2O. When needed, peptides were added at the concentrations 
corresponding to saturation ratio or higher. The samples were kept in sealed NMR 
sample tubes stored at 4 °C. 
Data collection: Data was acquired with 850 MHz Bruker Avance III HD spectrometer 
at 25 °C. The instrument was equipped with a 1H/13C/15N TCI CryoProbe and a 
SampleJet with temperature control set to 4 °C for sample storage. Data was collected 
at 25 °C.  
Backbone assignment, titration NMR and chemical shift perturbation: For 
sequential backbone assignment of CW in its free state and bound to peptides 2D 1H–
15N HSQC, 3D HNCACB and 3D CACBcoNH spectra were acquired. The assignment 
was performed using the CARA program v 1.9.1.2 [227]. HSQC type of experiment 
was also used to indicate conformational exchange regime (fast or slow) and saturation 
ratios of CW binding to peptides. For this, the titration series were prepared with 
increasing ratios of CW:peptide and for each point shift of the peaks positions or peaks 
intensities were monitored. HSQC spectra are sensitive to changes in the backbone 
conformations, and comparison spectra of CW in its free state and bound to peptides 
allowed the calculation of chemical shift perturbations (CSP) from the change of the 
peaks positions. This change indicates structural responses to binding. The sensitivity 
of HSQC was also used to verify the folded state of the mutants and estimate structural 
disturbances caused by them. 
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Analysis of backbone local dynamics with heteronuclear NOE, relaxation 
measurements and model-free analysis: Dynamics analysis was performed for CW 
in free state and bound to peptides. In order to perform model-free NMR analysis, 1H-
15N NOE values, 15N Longitudinal (R1 = 1/T1) and transverse (R2 = 1/T2) relaxation 
rates were acquired. For determination of heteronuclear NOEs, two 1H-15N HSQC data 
sets were recorded, using 3 s recycling delay between transients. For T1 and T2 
measurements sets of different relaxation delays were used (Table 2). 








16 30 60 95 125 160 190 220 250 345 440 500 
 
Analysis of the relaxation data was carried out in Bruker Dynamics Center 2.5.3 
(Bruker BioSpin). 1H-15N steady-state NOE, longitudinal and transverse relaxation 
rates (R1 and R2) were determined from cross-peak intensities/integrals in 1H-15N 
HSQC spectra. The heteronuclear NOE values were estimated as the ratio of the steady-
state intensities measured in the presence and absence of saturation of the proton 
magnetization. R1 and R2 parameters were obtained by fitting the peak intensities 
acquired at different relaxation delays to a two-parameter exponential decay function. 
The errors of the fitted parameters were calculated from the inverse of the weighted 
curvature matrix.  
More details on the methods description can be found in the Material and Methods 
sections of all three papers, under subheadings “NMR sample preparation”, “NMR data 
acquisition, processing and assignment” and “Titration experiments for CW42” in 
Paper I, “NMR spectroscpy” in Paper II, “NMR spectroscopy” and “Dynamics 
measurement” in Paper III. 
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3.6 Intrinsic tryptophan fluorescence spectroscopy 
Affinity measurements: Affinity measurements by intrinsic tryptophan fluorescence 
spectroscopy was used at the stage of the CW constructs selection. Most successful 
candidates with stable expression CW33, CW37 and CW42 in comparison to CWs 
from [90] were analysed. For this analysis two solutions were prepared, each 
containing equal amounts of a given CW version, to ensure constant concentration 
throughout the titration. In the second solution, an excess amount of peptide was added, 
and this solution was titrated into the first one. Typical titration series consisted of 9-
12 concentration points. The titration series were performed in triplicates for each CW 
in combination with H3K4me1, H3K4me2 and H3K4me3. The unmodified H3 
histone-tail peptide was used as a control. Representative blanks containing only 
histone peptides were titrated into T7 buffer. Intrinsic tryptophan fluorescence 
measurements were done at 25 °C, with excitation at 290 nm. The emission data was 
recorded in the 300-450 nm interval. Intensities, FOBS, at the wavelength giving the 
largest fluorescence change (319-322nm interval) were plotted as a function of histone 
peptide concentration. Then, the dissociation constant Kd was determined using a non-
linear least-squares fit to equation 4 [228,229]: 
� � = � � + � −�√ �+� + − �+� + 2−4�   (4) 
Here, Fp is fluorescence of the protein and Fpl is fluorescence of protein-ligand 
complex, Po and Lo are the total concentrations of the protein and the ligand.  
Thermal denaturation measurements: To assess the thermal stability of the CW 
domain and its change upon binding to peptides or due to mutations, the samples were 
subjected to thermal denaturation with monitoring the changes in tryptophan 
fluorescence in the 310 nm and 450 nm region after excitation at 295 nm. CW in free 
state, bound to peptides, and CW α1-helix mutants, also in free state and bound to 
H3K4me1 peptide, were analysed in the 5 – 90 °C temperature range, with 5 °C – 10 
°C stepwise increase in temperature. The samples containing only histone peptides 
were used as blanks. The measurements were done in triplicates. To find the melting 
3 8  
 
temperature Tm, the ratio of the fluorescence intensity at 335 nm and 355 nm [230] at 
each temperature point was plotted against the temperature with the subsequent fitting 
of a 4-parameter sigmoidal curve (equation 5):  � =  + ��+ −� −��      (5) 
Here, y0 is the slope of the pre-transition state, yf  is the slope of the post-transition state, 
Tm is the inflection point in the curve, and b is the slope at the inflection point. 
More details on the method description can be found in the Material and Methods 
sections under subheadings “Intrinsic tryptophan fluorescence” in Paper II, “Intrinsic 
tryptophan fluorescence affinity measurements” and “Thermal denaturation monitored 
by intrinsic tryptophan fluorescence” in Paper II supplementary materials, and 
“Thermal denaturation” in Paper III. 
3.7 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) was used to find thermodynamical parameters of 
interaction like the change in enthalpy ∆H, entropy ∆S and free energy ∆G, and find 
dissociation constants Kd. CW wt was titrated with methylated peptides and for control 
unmethylated H3 peptide and T6A mutant were also included in analysis. ITC was also 
performed for all CW mutants. Typical titration setup was 22 stepwise injections of a 
peptide to a sample, with 300 seconds intervals in between, performed in triplicates on 
Nano ITC from TA Instruments at 25 °C with a stirring rate of 300 rpm. As a blank, a 
peptide was titrated into T7 buffer only. Corrected heat flow peaks were integrated, 
plotted and fitted by independent modelling to determine binding parameters using the 
NanoAnalyze V 2.4.1 software. 
More details on the method description can be found in the Material and Methods 
sections under subheadings “Isothermal calorimetry” in Paper II, and “Isothermal 
titration calorimetry (ITC)” in Paper III. 
  
3 9  
 
4. SUMMARY OF THE RESULTS 
The general aim of the research was to understand and characterize the interaction 
mechanism of selective recognition of H3K4me1 histone modification by the CW 
domain of ASHH2 methyltransferase. The results of this research are presented in three 
papers that highlight different approaches and aspects of the study, supplementing each 
other.  
Paper I is a documentation paper describing back-bone, side-chains and peptide 
assignments of NMR spectra of the CW domain in free and bound states and analysis 
of protein-peptide ratio at which the complex is saturated. This information was a 
foundation for the next work in solving the structure and analyzing protein dynamics. 
(Published in Biomol NMR Assign 12(1):215-220). 
Paper II aimed to solve the NMR structure of the CW-H3K4me1 complex and assess 
the dynamics and internal motion of the protein in free and bound states. Complexation 
with the ligand was inspected with NMR diffusion, multiple angle light scattering 
(MALS) and size exclusion chromatography (SEC), as well as thermal denaturation 
analysis. A comprehensive assessment of the interaction mechanism was performed in 
comparison with previously reported by Liu and Huang, 2018 X-ray structure by the 
means of MD simulation. (FEBS J, published online ahead of print, 2020 Feb 21 DOI: 
10.1111/febs.15256). 
Paper III was focusing on biophysical aspects of the interaction mechanism, analyzing 
the leading forces of the interaction. Comparison of known CW domain structures 
revealed different structural features that were hypothesized to shape these interaction 
forces, therefor, along with the key interaction features highlighted in Paper II, were 
subjected to mutagenesis. Analysis of mutants together with wild type CW in free and 
bound to different peptides states was performed by isothermal titration calorimetry 
(ITC), thermal denaturation monitored by intrinsic tryptophan fluorescence 
spectrometry and NMR. (Manuscript). 
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4.1 CW-H3K4me1 complex structure and dynamics 
The study described in Paper II aimed to solve the structure of the CW-H3K4me1 
complex and determine the key elements involved in the interaction, as well as the 
overall interaction mechanism. Figure 10A shows the structural ensemble of 20 
minimized structural conformers consistent with the 1056 NMR determined restrains. 
By comparing NMR structures in free (apo) and bound (holo) states, four residues I915, 
L919, I921 and Q923 were identified to form the “ceiling” of the binding pocket, 
closing the monomethylated lysine (Figure 10B and C). Binding of the peptide causes 
moderate reorganization of the backbone of the protein. The most prominent 
differences between the backbones of the apo and holo states are approximately 8 Å 
shift of the η1-loop, due to interaction with the N-terminal of the ligand, and a minor 
reposition of the α1-helix (≈ 2 Å), which allows insertion of the methylated lysine into 
the binding pocket. NMR data and MD simulations also indicate involvement of the C-
terminal coil in the mediation of the interaction as it tends to shift towards the N-
terminal end of the ligand upon binding. MD simulation, hydrogen bond analysis of 
the complex and secondary structure analysis verified a stable intermolecular β-sheet 
augmentation, reinforced by hydrogen bonds between ligand and CW domain, and 
expansion of the domain’s β-sheets. ITC analysis of Q923A mutation indicated the 
presence of unspecific binding as the titration profile did not follow the sigmoidal 
trend, stating the importance of the Q923 residue in the interaction with the ligand. 
Characterization of internal motions of the apo and holo states by NMR indicates that 
the CW domain is quite flexible in both states, but acquiring an overall stabilization 
upon peptide binding. The most flexible regions of the apo state are shown in Figure 
10D. Complexation of CW with H3K4me1 ligand was also assessed for stability by 
intrinsic tryptophan fluorescence spectroscopy and hydrodynamic size estimations 
with size-exclusion chromatography (SEC) along with multi-angle light scattering 
(MALS) and diffusion constant measurements using pulsed-field NMR. Results from 
these methods showed that CW gets stabilized upon complexation with the ligand and 
gain a more compact form. Evidence for binding through conformational selection 
were found through applying CPMG relaxation dispersion experiments. The residues 
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D886 (from η1-loop), S907 and M910 (both from η3-loop) are characterized by slow 
exchange, i.e. a shifting between conformation on the ms-to-s timescale. In addition to 
η1-loop, which was shown to be important for binding, the dynamics and flexibility of 
the η3-loop, preceding the α1-helix, suggests a mechanism by which the α1-helix 
samples conformations upon binding with subsequent consolidation when the correct 
ligand is bound. 
In order to test the role of flexibility and the residues highlighted by the NMR analysis, 
mutagenesis with subsequent ligand affinity measurements were performed. 
Specifically, S907 and Q908 residues from the η3-loop were subjected to mutagenesis 
and analysis of the interaction with ITC. The flexible serine residue was mutated to 
glycine (more flexible) and proline (least flexible) residues [231]. S907P mutation 
resulted in increase of Kd value by approximately 3-fold (3.22 ± 0.29 μM, versus 1.09 
± 0.21 μM for wt), and the effect of S907G mutation on the interaction constant was 
insignificant when tested with H3K4me1. S907P and S907G failed to bind di- and 
trimethylated ligands. Q908 residue was replaced with a conserved glutamic acid, and 
the Q908E mutation resulted in a significant drop in affinity by 14-fold (18.75 ± 1.02 
μM).  
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Figure 10. NMR structure of CW bound to H3K4me1 and dynamics analysis. A – The 
structural ensemble of 20 minimized NMR-derived structures. B – structural 
superposition of CW in free state (brown, PDB code: 2L7P) and bound state (blue, 
PDB code: 6QXZ); the H3K4me1 ligand shown in orange. C – organization of binding 
pocket with I915, L919, I921 and Q932 residues colored in purple. D – conformational 
exchange values kex plotted on CW domain structure in free state (intence red color and 
thick stickes represent higher kex values and quicker motion; yellow color and thin 
stickes represent smaller kex values and slower motion). A, B and C prepared with 
Chimera, and D prepared with PyMol. 
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4.2 Aspects of ASHH2’s CW-domain selectivity 
The study in Paper III aimed to identify the determinants that account for the selectivity 
of the domain towards H3K4me1. First, CW wild type in complex with three peptides 
(H3K4me1, H3K4me2 and H3K4me3) was characterized by HSQC experiments and 
chemical shift perturbations (CSP) indexing. Overall, the binding of all three peptides 
affected the structure of the domain in a similar way. Complexation with H3K4me3 
peptide showed higher CSP values, as a larger methylated residue introduces a steric 
strain on the whole CW’s structure. When interacting with the H3K4me1 peptide, a 
disordered region I921-Q923 succeeding the α1-helix showed higher CSP values. This 
suggests that this region might be involved into selectivity towards H3K4me1 peptide, 
which is in agreement with the mutation analysis of Q923, a residue which is also part 
of a NOE network that stabilize the domain in complex with H3K4me1. Closer 
inspection of HSQC signals from side chains of tryptophans forming the binding 
pocket and asparagines at the α1-helix indicated that complexation of wild type with 
the peptides affected the structure of the binding pocket and the α1-helix orientation 
differently, resulting in three different conformational states of the domain. 
Interaction of the domain with peptides was also assessed by ITC. Results show that 
the interaction is driven by enthalpy. From the enthalpy-entropy contribution, it is seen 
that the interaction with H3K4me1 peptide is the most favorable, resulting in the lowest 
free energy of the system and the lowest Kd value. 
Comparison of known CW structures from different protein families revealed a small 
loop region between β-sheets that differs between the paralogs. The length and 
composition of this loop might hypothetically affect the positioning of the β-sheets in 
relation to each other, and thus affect the orientation of tryptophan’s side chains that 
form the binding pocket, and, therefore, this loop might regulate selectivity of the 
domain. To analyze this hypothesis, the CW-M3loop and CW-Z1loop mutants were 
prepared with the loop in ASHH2 matching the MORC3 and ZCWPW1. The mutants 
were assessed for changes in the interaction constants by ITC. HSQC fingerprinting of 
these mutations showed significant structural disturbance for the CW-Z1loop sample, 
which resulted in weakened binding and the interaction could not be characterized. 
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CW-M3loop construct did not show any big structural reorganization and resulted in 
an insignificant increase of Kd value (1.37 ± 0.32 μM). None of these mutations resulted 
in a change of specificity. 
Paper II and work previously published by Liu and Huang, 2018, identified I915 and 
L919 residues as key residues in locking the ligand in the binding pocket. Liu and 
Huang, 2018, prepared and determined by ITC the affinities of I915A and L919A 
mutants towards mono-, di- and trimethylated peptides. They reported a change of 
selectivity for I915A mutant. We repeated the analysis of these mutants and subjected 
them to thermal denaturation, HSQC fingerprinting and ITC analysis to assess the 
contribution of these amino acids to selectivity and stability of the domain. Both of 
these mutations resulted in a prominent structural disturbance as about 60% of all the 
domain signals at HSQC spectra were significantly shifted (more than 0.2 ppm). The 
mutations also affected the thermal stability of the domain, reducing it by 10 °C, and 
increasing the interaction constants Kd by ten-fold (12.17 ± 2.10 μM, versus 1.09 ± 0.21 
μM for wt).  
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5. GENERAL DISCUSSION 
The aim of the study was to explore the determinants underlying the specificity and 
stability of the ASHH2 CW-domain with a particular interest in the role of the C-
terminal α1-helix and disordered regions. Structural analysis and comparison with 
other known structures of CW domains also suggested a hypothesis that the specificity 
of the domain might be conditioned by the flexible loops. To approach this objective, 
we analyzed the interaction of the wild type in more detail, followed by mutation 
studies with the aim of directly test the relevance of residues positioned in loops and 
other high-mobility elements of the domain. 
5.1 Binding mechanism of ASHH2’s CW-domain 
Liu and Huang, 2018, explored the interaction mechanism by the means of 
crystallography and explained it in terms of lock-and-key binding model [101]. Trying 
to avoid the limitations of their work (use of the E917A mutant and a short construct 
to enable crystallization), the NMR structure was solved with the assessment of the 
dynamic behavior of the structure in free and bound states. From these results, the 
structure of the CW domain appears to be flexible even when complexed with peptides. 
HSQC fingerprinting and inspection of side chains signals of tryptophans, forming part 
of the binding pocket, and asparagines from α1-helix presented in Paper III, showed 
that the domain attains different conformational equilibriums when bound to different 
peptides. MD simulations indicated that complexation with monomethylated peptide is 
followed by β-sheet augmentation of the ligand. These observations lead to the 
conclusion that the interaction mechanism of the CW domain is better characterized by 
conformational selection and induced fit models of interaction, rather than lock-and-
key. 
The C-terminal α1-helix is flanked by two unstructured regions: the η3 “hinge” region 
and the I921-Q923 region. Mutation analysis indicates that S907 residue, which shows 
high mobility, allows movement of the α1-helix to open the binding pocket for the 
methylated residue of the peptide. The residue and the helix are getting stabilized when 
the domain is complexed with H3K4me1 ligand. Interaction with the peptide is 
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finalized by locking it with the I921-Q923 region. The flexibility of the η3 and I921-
Q923 regions allows positional adjustment of the α1-helix into a favorable orientation 
when the CW domain is bound to H3K4me1 peptide. 
5.1.1 Assessment of NMR and Crystal structures 
Coinciding with the convergence of the NMR structure solved in this work, an X-ray 
structure of CW in complex with H3K4me1 peptide was published by Liu and Huang, 
2018 [101]. They also identified the η1-region, I915 and L919 residues as the key 
features of the binding mechanism and discussed the interaction in terms of lock-and-
key binding. While both structures represent a domain removed from its functional 
context, the crystal structure has several additional limitations. To solve the crystal 
structure, the E917A mutant was prepared in order to generate stable crystals. 
Moreover, a shorter version of CW, terminated at I921, and therefore devoid of C-
terminal coil region, was used in their work. The H3K4me1 mimicking peptide was 
also shorter and included residues from 1st to 7th, while the peptide from 1st to 9th 
residues of the H3 tail was used for NMR structure. It could also be argued that crystal 
structures, while usually high in resolution, are inherently biased towards static and 
compact structures [232,233].  
Having access to structural models solved by independent techniques lends a more 
complete picture when considering the strengths and weaknesses of both cases. While 
overall, the structures match, there are differences in positioning of C-terminal α1-helix 
and displacement of Cαs by roughly 4 Å, which are likely a result of the limitations of 
the Liu and Huang’s approach. In the NMR structure, the ligand in the binding pocket 
is “surrounded” by the I921-Q923 coil, which is missing in the crystal structure, leaving 
the ligand open. Other differences were observed in the orientation of the ligand for 
residues Q5-A7, and some conformers of the NMR structure suggest the formation of 
β-sheet by peptide. This, however, was not seen in the crystal structure. To 
comprehensively asses the structures, MD simulations were run for the NMR structure, 
X-ray structure, and a shortened NMR structure, made to match the X-ray in length. 
We observed that the crystal structure is much more restricted in its movements, which 
suggests that the structure is trapped in a conformation that is difficult to escape from. 
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Hydrogen bond and secondary structure analysis derived from MD simulations of both 
structures showed β-augmentation, but with some differences in the ligand’s residues 
involved in the interaction (A2 to Q5 for the X-ray structure and T3 to A6 in the NMR 
structure). MD simulations run on the full length and truncated NMR structures 
indicated an increase in flexibility of the α1-helix and β1-sheet in the structure devoid 
of the C-terminal coil, which, again, suggests a role of the C-terminal coil in the 
stabilization of the ligand and the overall complex upon its binding. 
Identified by both X-ray and NMR structures as the key residues that stabilize the 
methylated lysine sidechain inside the binding pocket, I915, L919 and Q923 were 
subjected to mutagenesis. ITC analysis performed by Liu and Huang, 2018 did not 
include Q923, as the construct used in their work was devoid of this residue. The 
conclusion was that I915 is a regulatory residue responsible for selectivity towards 
H3K4me1 peptide. Close inspection of their results indicated that the experimental 
setup was not properly optimized, as the reported stoichiometric coefficients of 
interaction derived from their analysis deviate substantially from 1 [187]. The mutation 
analysis was repeated and the function of I915 and L919 residues was accessed by ITC 
and fluorescence spectrometry. Results presented in Paper III did not verify the 
involvement of these residues into regulation of selectivity, and suggested that these 
residues function by stabilization of the domain’s fold, probably by protecting the 
tryptophan residues from unfavorable solvent interactions in the absence of ligand. 
HSQC fingerprinting of these mutants showed significant shift of the signals as the 
result of structural disturbances, which indicates that the CW domain is very sensitive 
to mutations in this region. 
5.2 Characterization of CW domain selectivity 
After characterization of the interaction mechanism of the CW domain with H3K4me1 
peptide in Paper II, the question of selectivity was addressed further in Paper III.  
The CW domain in complex with histone mimicking peptides was analyzed by HSQC 
type of experiments followed by chemical shift perturbation indexing of the CW’s 
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backbone. Binding to all three peptides causes similar structural disturbances, which 
also affect the domain outside the immediate vicinity of the binding pocket. Notable 
difference is that binding to H3K4me3 peptide resulted in slightly higher values of CSP 
for most of the residues. Strain induced by the H3K4me3 peptide in the binding pocket 
is also reflected in thermal denaturation analysis, where complexation with the peptide 
decreased the thermal stability of the domain. Binding to H3K4me1 had the highest 
CSP values for the I921-Q923 region, suggesting its involvement in selectivity. 
Results from analysis of NMR dynamics of the CW complexed with peptides showed 
that the I921-Q923 region is getting stabilized the most when the CW binds H3K4me1, 
again suggesting involvement of this region in selectivity. 
Calorimetric analysis by ITC showed that the interaction is driven by enthalpy that 
overcomes an entropic barrier. In the lock-and-key binding model it is the entropy that 
drives the interaction [192,193] and as our results show that the interaction of CW with 
the ligand is enthalpy driven, it is an argument in favor of conformational selection and 
induced fit mechanism [192,194]. A balance between enthalpy and entropy 
contributions is reflected in differences in dissociation constants for CW in complex 
with peptides. Binding to H3K4me1 has the lowest Kd value and H3K4me3 has the 
highest, which is in agreement with Hoppmann et al., 2011 and Liu and Huang, 2018. 
Enthalpy has the lowest value when CW is bound to H3K4me1 peptide, and, as the 
enthalpy in the non-strict terms characterizes the sum of the energies of non-covalent 
bonds, which were formed upon complexation [192,195], the CW-H3K4me1 complex 
obtains more of the protein-ligand and intradomain connections. These connections are 
likely the contacts made by the I921-Q923 region with the ligand and the formation of 
hydrogen bonds by β-sheet augmentation.  
Taking together, the results from chemical shift perturbation analysis, analysis of the 
domain’s dynamics and calorimetric analysis of interaction it is possible to conclude 
that I921-Q923 region is an important determinant that contributes to selectivity of the 
CW domain towards H3K4me1 peptide, as in cases of interaction with H3K4me2 and 
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H3K4me3 this region fails to make stable contacts and stabilize the structure of the 
complex, resulting in reduced Kd values and reduced thermal stability. 
5.3 Sub-type specific determinants of CW domain’s selectivity 
CW domain family is represented by several known structures originated from different 
protein families. These CW share core structural elements, like tryptophan binding 
pocket, located at the antiparallel β-sheets, and Zn2+ ion that maintains the structure via 
coordination by cysteines. The rest of the fold is variable for the individual domains. 
The domains exhibit different preferences towards the methylation state of the ligands. 
While ASHH2’s CW is more specific towards H3K4me1, others were shown to prefer 
H3K4me3 and me2 modifications [90,92,95,96]. Comparative analysis of known 
structures revealed variable structural elements which might be involved into 
selectivity of a domain. In case of ASHH2’s CW domain, the C-terminal α1-helix is 
one of such features. A closer look at the geometry of the binding pocket showed that 
the angle between the tryptophans differ for the domains, and ASHH2 has the smallest 
of them. Limited space of the binding pocket might, therefor, also contribute to the 
domain’s preference towards “smallest” monomethylated ligand. Since the tryptophans 
that form the binding pocket are located at the β-sheets, their orientation and, thus, the 
angle between them will depend on these β-sheets relative arrangement. The β-sheets 
are connected by a loop, variable in length and amino acid composition, which 
hypothetically might affect the geometry of the binding pocket.  
Possible involvement of these structural features into selectivity was investigated by 
analysis of the mutants. Mutant that was lacking the α1-helix was first generated by 
Hoppmann et al., 2011 and was shown to lose its binding activity [90]. Going deeper 
into studying this construct revealed that the loss of activity was due to fold disruption, 
suggesting the conclusion that the α1-helix’s function is fold maintenance. Thermal 
stability analyses of I915A and L919A α1-helix mutants indicated that the fold is 
stabilized by I915 and L919 amino acids, most likely due to their orientation inside the 
binding pocket, where these amino acids together with tryptophans create and maintain 
a hydrophobic environment. HSQC spectra of these mutants also revealed great 
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structural disturbances introduced by these mutations on the overall fold, including the 
chemical environment around the tryptophan side chains in the binding pocket. It is, 
however, very difficult to completely deconvolute the α1-helix effects on fold stability 
and binding specificity, as they inevitably affect each other. 
Analysis of mutants with variable loops, when ASHH2 CW domain was generated to 
have the loop connecting β-sheets to be the same as for CW from MORC3 and 
ZCWPW1 proteins, did not indicate any change of selectivity. HSQC spectra showed 
a disturbance of the overall fold, resulting in loss of binding (for CW-Z1loop) or 
reduced affinity (for CW-M3loop). 
These observations contribute to the conclusion that the interaction mode of the CW 
domain and its recognition of ligand is better characterized by flexible and dynamic 
conformational selection model, rather than lock-and-key binding, as none of the 
analyzed mutations resulted in a shift of preference, but rather introduced structural 
disturbances that often encompassed the entire fold. 
5.4 CW function in context of full length ASHH2 enzyme 
Although the objectives of the present study were concerned mainly with the 
interaction mechanism of CW alone, the presented findings can be discussed in the 
light of the full length protein. Changes in conformation associated with CW binding 
to the histone tail modified at H3K4me1 residue might potentially contribute to 
regulation of SET-domain positioning and orientation. Thus, repositioning of the C-
terminal region closer to the backbone of the histone might allow adjustment of the 
SET-domain positioning towards H3. Formation of β-sheet by the region of the histone 
bound by CW might be required for the orientation of the target H3K36 residue in the 
vicinity of the SET domain’s active site. 
Another possible function of ASHH2 CW-domain can be hypothesized by 
extrapolation from other CW containing proteins. For example, for human MORC3 
ATPase it was shown that CW regulated its enzymatic activity by autoinhibition. The 
enzyme is activated only after binding to H3 histone tail [234]. CW of ASHH2 might 
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be involved in the activation of the SET-domain by a similar mechanism. For MORC3, 
it was also shown that the active state of the enzyme bound to DNA and histone tail 
drives phase separation and concentration of free DNA within its droplets [235]. 
Although ASHH2 does not interact directly with DNA, a similar effect can be inherent 
to its function. The interaction environment of ASHH2 with H3 histone and the binding 
of the methyl group donor S-adenosyl-methionine (SAM) utilized by the SET-domain 
might shift the equilibrium of the phase separated heterochromatin towards its active, 
loose structure. Another example is the CW domain of LSD2 amine oxidase. Despite 
being inactive and not binding histone tails, it contributes to the overall stability of the 
enzyme and is required for its activity [96-99].  CW of ASHH2 can also be an important 
determinant in the overall structural maintenance of the whole enzyme. 
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6. CONCLUDING REMARKS 
In this study we aimed to characterize and understand the interaction mechanism by 
which CW domain from ASHH2 methyltransferase selectively recognize H3K4me1 
histone modification and differentiate between mono-, di- and trimethylated state. A 
complementary structural and biophysical approach, combining high and low 
resolution techniques, prompted us to question the fundamental nature of the 
interaction mechanism as assumed in existing literature. Calorimetric, dynamic and 
mutational analysis showed that the binding and specificity of ASHH2 CW domain 
towards H3K4me1 is better described by the conformational selection mechanism and 
conditioned by energetically favorable enthalpy driven interaction. Furthermore, low 
affinity towards H3K4me3 peptide is associated with a small size of the binding pocket 
at equilibrium and decreased stability of the CW-H3K4me3 complex. NMR 
fingerprinting of the mutants showed how sensitive the CW domain is to mutations, 
especially in the C-terminal α1-helix region, and analysis of the mutants verified that 
the α1-helix and the C-terminal tail is an important determinant of the structure 
stabilization and binding affinity, functioning via intradomain interaction of L919 and 
I915 residues with the tryptophan side chains in the binding pocket. Finally, upon 
complexation with H3K4me1 ligand, the repositioning of the α1-helix is mediated by 
unstructured I921-Q923 and η3 regions. 
6.1 Future perspectives 
The role of the CW domain in the context of full length protein is yet to be understood. 
The movement of the unstructured C-terminal coil and the formation of β-sheet by 
histone tail might be a part of the mechanism which regulates the positioning of the 
SET-domain along H3 histone ensuring its activity. Zhang et al., 2019 presented 
evidences that CW is involved in the regulation of the enzymatic activity of the ATPase 
domain of the human MORC3 protein, releasing autoinhibition by CW after binding to 
H3 histone tail [234]. ASHH2’s CW might as well function in a similar way. Solving 
the structure of the full length enzyme in the free state and in the complex with H3 
histone, will help to characterize the function of the enzyme. Use of histone mimicking 
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peptides or recombinant histones will not allow analysis of possible effects of 
neighbouring modifications and associated chromatin DNA. However, these 
limitations can be overcome by the use of purified nucleosomes. 
Another possible function can be hypothesized from works done by Dong et al., 2008 
and Xu et al., 2008. Comparison of the results from methyltransferase assays with 
radiography labeled methyl group donor that used constructs of different architecture 
(full length construct and a construct devoid of CW domain, consisted of AWS-SET-
PostSET domains only ) suggests that the CW domain of ASHH2 methyltransferase 
might function by regulating the SET domain activity restricting it specifically towards 
H3 histone, as the construct that was lacking CW domain was able to transfer the 
methyl group in vitro not only to H3 histone but also to H4 [105,236]. This setup could 
be repeated to verify the hypothesis and expanded with structural biology analysis to 
understand the function of CW in such context. 
As ASHH2 methyltransferase itself appears in the wider context at the chromatin level, 
likely as a part of a cromatin remodeling or mediator complexes, it is worth also 
switching the attention from in vitro characterization to in vivo and try to assess its 
function in the context of a living cell.  To shift the focus from the domain’s function 
and answer the questions of the composition and structure of ASHH2 containing 
complexes and the identification of associated genes that are regulated by them, a 
combinatorial approach of modern methods of proteomics, sequencing and cryo-EM 
would have to be utilized. Proteomics could provide qualitative and quantitative 
characterization of the protein complexes and highlight their structure and organization 
by cross-linking mass spectrometry. Proteomics coupled with sequencing could 
identify the genomic regions at which the ASHH2 containing complexes function and 
their dynamics during cell cycle. Cryo-EM can provide structural information at higher 
resolution and reveal organization of a protein complex together with the nucleosome 
it is attached to. 
Phase separation effects have been attributed to the activity of CW containing MORC3 
ATPase enzyme [235]. ASHH2 potentially might also be involved in similar 
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mechanisms of chromatin structure regulation. To assess possible involvement of 
ASHH2 in phase separation events, methods combining experiments with fluorescently 
labeled enzyme in mixture with purified nucleosomes and methyl group donor S-
adenosyl-methionine (SAM) will allow its characterization in vitro, and studying 
genome-edited cells expressing such fluorescently tagged protein will potentially 
reveal its action in native condition in vivo. 
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Chromatin post-translational modifications are thought to be impor-
tant for epigenetic effects on gene expression. Methylation of histone
N-terminal tail lysine residues constitutes one of many such modifica-
tions, executed by families of histone lysine methyltransferase
(HKMTase). One such protein is ASHH2 from the flowering plant
Arabidopsis thaliana, equipped with the interaction domain, CW, and
the HKMTase domain, SET. The CW domain of ASHH2 is a selec-
tive binder of monomethylation at lysine 4 on histone H3 (H3K4me1)
and likely helps the enzyme dock correctly onto chromatin sites. The
study of CW and related interaction domains has so far been empha-
sizing lock–key models, missing important aspects of histone-tail CW
interactions. We here present an analysis of the ASHH2 CW-
H3K4me1 complex using NMR and molecular dynamics, as well as
mutation and affinity studies of flexible coils. b-augmentation and
rearrangement of coils coincide with changes in the flexibility of the
complex, in particular the g1, g3 and C-terminal coils, but also in the
b1 and b2 strands and the C-terminal part of the ligand. Furthermore,
we show that mutating residues with outlier dynamic behaviour affect
the complex binding affinity despite these not being in direct contact
with the ligand. Overall, the binding process is consistent with confor-
mational selection. We propose that this binding mechanism presents
an advantage when searching for the correct post-translational modifi-
cation state among the highly modified and flexible histone tails, and
also that the binding shifts the catalytic SET domain towards the
nucleosome.
Abbreviations
H3, Histone H3; H3K4meX, histone-tail peptide methylated 0-3 times at position K4; MALS, multi-angle light scattering; MD, molecular
dynamics; PTM, post-translational modification; RMSF, root mean square fluctuation; SEC, size-exclusion chromatography; WT, wild-type.
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Databases
Structural data are available in the PDB database under the accession code 6QXZ. Resonance
assignments for CW42 in its apo- and holo-forms are available in the BMRB database under
the accession code 27251.
Introduction
Chromatin structure, and thereby gene expression, is
dynamically regulated by post-translational modifica-
tions (PTMs) on the N-terminal histone tails protrud-
ing from nucleosomes. These PTMs include
methylation, acetylation, phosphorylation and many
other modifications. They are thought to constitute a
histone code, where unique combinations of PTMs are
associated with specific effects on gene expression [1].
The PTMs are established and altered by ‘writer’ and
‘eraser’ enzymes that add and remove modifications,
respectively, and the ensuing pattern of PTMs on the
histone tails is interpreted by ‘reader’ protein domains
[2]. Methylation of histone N-terminal tail lysine resi-
dues is carried out by methyltransferases that harbour
a catalytic SET domain, and target lysine residues can
either be mono-, di- or trimethylated on the ɛ-nitrogen
[3]. The modified lysine residue can be demethylated
by one of two classes of lysine demethylases, either a
flavin adenine dinucleotide-dependent oxidase or a Fe
(II) and a-ketoglutarate-dependent hydroxylase [4].
Methylated lysine residues can be recognized by mem-
bers of the ‘royal family’ of protein domains, which
are the chromo, MBT, chromo barrel, Tudor and
PWWP domains [5]. It is also known that some WD40
domains and PHD fingers can recognize unmodified or
methylated lysine residues [6]. The CW domain family
has also been identified as another family of proteins
that can recognize methylated lysine residues both in
animals [7] and in plants [8].
The CW domain family is named after and identi-
fied by conserved cysteine and tryptophan residues
found in its primary structure. Proteins containing the
domain have been found in higher-order plants, verte-
brates and vertebrate-infecting parasites [9,10]. The
CW domain is found in proteins in combination with
other domains such as PWWP and SET, and it has
also been identified in chromatin remodellers and
demethylases [7–13]. The role of the CW domain in
most proteins is to recognize and bind to methylated
histone H3 (H3) N-terminal tails at the K4 position
(H3K4meX, where X is the number of methyl groups).
Depending on the protein, the CW domain displays a
different specificity for the degree of methylation
[7,8,14]. The other mammalian CW domain-containing
proteins ZCWPW1, ZCWPW2, MORC3 and MORC4
display specificity for H3K4me2/me3 [7,11]. CW con-
taining multidomain proteins found in animals and
plants are not orthologues, and their overall domain
organizations are different [9].
The small, flowering plant Arabidopsis thaliana
codes for an enzyme named ASHH2 which methylates
position K36 on H3. This 1759-amino acid-long
enzyme contains a CW domain that binds specifically
to monomethylated H3K4 followed by an AWS
domain and then a SET domain where the methyl-
transferase activity resides [8]. ASHH2 is a major regu-
lator of growth and development in Arabidopsis, as
mutations in ASHH2 result in dwarf plants with alter-
ations in flowering time, fertility, branching, organ
identity, programmed cell death and pathogen defence
[15,16]. ASHH2 di- and trimethylates H3K36 from
their monomethylated state, and in loss-of-function
mutant plants, a global reduction in H3K36me3/me2
and a corresponding increase in H3K36me1 are linked
to an early flowering phenotype [17,18]. Further pleio-
tropic effects include reduced fertility as well as
homeotic changes in floral organs in plants where the
ASHH2 gene is mutated [19,20]. Arabidopsis also con-
tains another H3K36 methyltransferase ASHH1, but
in contrast to ASHH2, this protein lacks a CW
domain and based on the severe pleiotropic effects of
the ASHH2 mutant the two proteins are not redun-
dant [18].
In recent years, several structures of CW domains in
their apo and holo, that is their unbound and bound
states, have been solved [7,8,14,21]. A shared feature
of interaction is the conserved tryptophans scaffolded
by a b-sheet which provides part of the pocket that
accepts the methylated lysine. Another feature of CW
domains not highlighted by earlier investigations is the
fact that their tertiary structure comprises just a few
short secondary structure elements, while flexible coils
dominate the rest of the fold. Disorder and flexibility
are prevalent both in histone tails and in proteins
involved in chromatin remodelling, and recent bioin-
formatic studies have highlighted the need for investi-
gations focusing on functional flexibility [22,23]. As far
as we can determine, the structural biology of CW
domains has not been investigated systematically with
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functional flexibility in mind. We are therefore inter-
ested in whether CW binding is coupled to changes in
structure, stability and mobility at the level of individ-
ual amino acids, and secondary and tertiary levels of
organization. To explore this question, a comprehen-
sive structural and dynamic analysis of the ASHH2
CW-H3K4me1 complex using NMR, molecular dynam-
ics (MD) and lower-resolution techniques were per-
formed, followed by mutagenesis of residues implicated
in functional flexibility to assess their effect on affinity.
From our analysis, ASHH2 CW emerges as a dynamic
domain that undergoes a global reorganization to
become more compact but still remains relatively flexi-
ble. We found that the mechanism of binding relies on
protein flexibility and is best described by a conforma-
tional search for the correct histone modification. CW
domains have not yet been reported to act through such
mechanisms, and it is possible that this mechanism con-
fers an advantage in the highly complex and dynamic
chromatin environment.
Results
The CW domain reorganizes to a more compact
form upon binding to H3K4me1
The functional domains of ASHH2 lie within long
stretches of amino acids that are predicted to be disor-
dered or to contain orphan secondary structure not
associated with any known fold. Among the folded
domains, CW is N-terminally situated and is also
flanked by disordered segments (Fig. 1A). The NMR
structure of the unbound ASHH2 CW domain was
determined by Hoppmann et al. [8] using a construct
denoted CWs (PDB code: 2L7P, Fig. 1A). For struc-
ture determination of the complex, a screen of 20 addi-
tional constructs was subsequently performed, initially
aimed at finding expressible and high-affinity binders
amenable for co-crystallization with the bound ligand.
Of these, the constructs denoted CW33, CW37 and
CW42, all covering the evolutionary conserved resi-
dues of the CW domain (Fig. 1A), where high-affinity
binders of the histone tail mimick H3K4me1 (ARTK-
me1QTARY, with one methyl substitution at the f-po-
sition of K4), as determined by an intrinsic
fluorescence-based binding assay (Kds in the range of
0.21–0.85 µM Fig. 1B-D). Their affinities for H3K4me2
and H3K4me3 were also determined (sequence as for
H3K4me1, but with two and three methyl substitu-
tions at K4, respectively), and the Kd values ranged
from 0.7 to 7.3 µM (Fig. 1D, examples of binding
curves in Fig. S1). Several crystallization attempts
were unsuccessful, and consequently, the decision was
made to characterize the complex using NMR. For
subsequent work, CW42 construct was selected as it
expressed well and had an affinity indistinguishable
from that of the longer CWs [24].
One noticeable property of the fluorescence binding
studies was that the ligand caused a kmax shift towards
shorter wavelengths of the spectrum (Fig. 1B). Such
behaviour is characteristic of tryptophans entering a
more solvent-protected environment within a fold [25].
This makes sense if the ligand covers the two trypto-
phans of the binding site upon binding, if there is a
consolidation of the overall fold of the domain upon
binding or both. We, therefore, compared the tempera-
ture stability of the apo- and holo-forms using intrinsic
tryptophan fluorescence, as well as estimating their
hydrodynamic sizes. We found that the Tm of the
CW42-H3K4me1 complex was about 6 °C higher than
that for uncomplexed CW42 (Tm of 58.0  1.4 °C vs
64.4  1.0 °C, Fig. 2A,B). For size estimations, size-
exclusion chromatography with multi-angle light scat-
tering (SEC-MALS) was used as well as diffusion con-
stant measurements using pulsed-field NMR. MALS
data showed lower effective hydrodynamic radius, that
is the elution time on an SEC column increases, even
as the molecular mass of the complex goes up
(Fig. 2C). The holo-state also shows a shoulder
towards the unbound state. Curiously, increasing the
ligand concentration beyond further beyond twofold
excess did not remove this feature. The NMR diffu-
sion rate measurements collected for the protein and
the complex support this observation. The observed dif-
fusion rates correspond to roughly 2.11010 m2s1 and
2.61010 m2s1 for the apo- and holo-forms (Fig. 2D).
Using the Stokes–Einstein relationship [26], these diffu-
sion rates correspond to approximate hydrodynamic
diameters of 1.7 and 1.4 nm, respectively. The Tm,
MALS and diffusion data support the view that the
domain undergoes compaction and stabilization of its
structure upon ligand binding. In the following, we elu-
cidated how this was reflected in the structure and
dynamics of CW42 at a more detailed level.
Apo- vs holo-structural comparison shows C-
terminal a1-helix differences and posthelical coil
involvement in binding
The most suitable approach for exploring the detailed
in-solution molecular changes associated with the
binding is comparing the NMR structures of the apo-
and holo-forms of CW. Previously, we published the
structure of the free ASHH2 CW domain [8], and
now, we present the solution structure of the CW42-
H3K4me1 complex. The structure was submitted to
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the Protein Databank (PDB code: 6QXZ), and a sum-
mary of NMR structural statistics and an ensemble
representation of the 20 energy-minimized conformers
can be viewed in Fig. 3A,B. In Fig. 4A, the apo-struc-
ture (PDB code: 2L7P, Hoppmann et al. [8]) and the





















































Wavelength, nm H3K4me1 concentration, μM










4 The FEBS Journal (2020) ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
ASHH2 CW acts through conformational selection O. Dobrovolska et al.
and the position of the side chain of K4me1 are sug-
gestive of cation–p interactions with the indole group
of W874 [27] (Fig. 4A). Four residues comprise the
top of the hydrophobic pocket hosting the
monomethylated lysine: I915, L919, I921 and Q923
(Fig. 4B,D). All of these residues display NOE connec-
tivities with the ligand, indicating stable contacts in
solution (see examples in Fig. 3C). A comparison
between the backbone of the apo- and the holo-NMR
structures does not indicate a large reorganization of
the protein domain upon binding. The most prominent
difference is in the g1-loop that changes position to
interact with the N-terminal of the ligand (backbone
displaced by up to 8 A). There is also a minor reposi-
tion of the C-terminal a1-helix to accommodate the
ligand (backbone displaced by ~ 2 A), as predicted in
the Hoppmann et al. paper [8].
A crystal structure of the ASHH2 CW domain in
complex with H3K4me1 has also recently been pub-
lished by Liu et al. (PDB code: 5YVX) [14]. The g1
region, as well as the I915 and L919, was identified as
crucial for ligand binding, and the interactions were
discussed in terms of lock–key arguments for the N-
terminal part of the ligand. To exploit all existing
structural data, we also include this crystal structure in
our analysis. Comparing the two known holo-struc-
tures shows that their backbones match closely except
at the a1-helix (Fig. 4C, RMSD between residues
S863-Q908 of the holo-forms is 0.913 A), a part of the
domain that is crucial for correct binding [8,14]. In the
Liu et al. structure, this helix is longer than the holo-
NMR structure, and the structure terminates immedi-
ately after the helix. Moreover, the Cas is displaced by
roughly 4 A towards the C-terminal end of the helix
(Fig. 4C) relative to our NMR structure. In order to
make the protein domain crystallize, Liu et al. intro-
duced an E917A mutation into the a1-helix at a site
that is partially conserved (Fig. 1A). While this muta-
tion still allowed the ligand to bind with a somewhat
reduced affinity [1.3  0.2 mM (WT) vs
2.79  0.36 mM (E917A)], it may together with the
lack of the C-terminal coil have caused the a1-helix to
become displaced relative to the NMR structure of the
wild-type version of the domain. Liu et al. [14] report
that N916, located within the a1-helix and positioned
next to the E917A mutation, is crucial for both bind-
ing of the methylated ligand and the methylation-de-
pendent binding profile of the CW domain. In our
structure, we find no evidence for stable contacts
between it and the ligand, and at the same time, the
ligand is in our case surrounded by the key residues
(Fig. 4B,D). We also note that between L919, I921
and Q923, there are two glycines (Fig. 4D). These
make no contacts with the ligand, but allow the key
residues space and flexibility they need to pack tightly
around the ligand. This is markedly different than the
configuration found in the crystal structure (Fig. 4E).
The CW42-H3K4me1 complex is stabilized by
intermolecular b-augmentation, the a1-helix and
the C-terminal coil
Several related structures, including that of MORC
and zinc finger CW, report b-augmentation as being
part of the binding mechanism, that is that an inter-
molecular b-sheet is formed upon binding [7,21,28].
To examine whether this is a stable feature of the
CW42-H3K4me1 complex, three replicates of 50-ns
Fig. 1. The CW domain of ASHH2 binds H3K4me1 with high affinity. (A) ASHH2 domain organization, with multiple sequence alignment of the
evolutionarily conserved CW domains from dicotyledonous flowering plants (Arabidopsis thaliana, Q2LAE1), monocotyledonous (maize, Zea
mays, A0A1D6HAE7), liverworts (Marchantia polymorpha, A0A2R6W143), spikemosses (Selaginella moellendorffii, D8SGM1), mosses
(Physcomitrella patens, A0A2K1L195) and green algae (Chlamydomonas reinhardtii, A0A2K3DEA3). The codes in parenthesis identify the
UniProt entries used in the alignment, which was generated using ClustalW. Mutations performed in this study (▼), the Hoppmann et al study
( ) and the Liu et al. study ( ) are indicated on the sequence. The CW core that is conserved across species, as well as secondary structure
elements, is shown below the multiple sequence alignment, as is a subselection of 3 of the 20 constructs initially prepared as possible
crystallization candidates and how they relate to the main sequence and the CW construct used in the Hoppmann et al. paper. (B)
Representative intrinsic tryptophan fluorescence spectra (excitation wavelength 290 nm) used for binding assays of CW42 to H3K4me1. The
vertical line indicates the wavelength at which emission intensities were used, as determined in the inset. Inset: DFluorescence intensity
where spectra of CW42 in the absence of any ligand are subtracted from spectra of increasing amounts of H3K4me1. Units are otherwise the
same as in the main panel. The wavelength at which the DFluorescence intensity was maximal was 322 nm for CW42, and in the range of
319–322 nm for the other constructs. (C) Kd determinations of CWs (—), CW42 ( ), CW37 ( ) and CW33 ( ). Normalized DFluorescence
intensity values at the wavelength as determined in the inset of Panel B were plotted against ligand concentrations (0.0–7.2 lM H3K4me1).
For CWs and CW42, the wavelengths used were 321 and 322 nm, respectively. Protein concentrations were constant throughout anyone
titration, but could vary somewhat from construct to construct (always within 2.0–2.4 lM). The data were fitted using nonlinear least-square
methods to Eq. 1, yielding three Kd values in each instance. (D) Tabulated affinities (in µM) of CW33, CW37, CW42 and CWs binding to
H3K4me0/1/2/3. N.a., not applicable, n.d., not determined. Values are given as means of each individual Kd determined within sets of matching
parallels. Error bars are one standard deviation, n = 3.
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Fig. 2. CW42 becomes more stable upon binding to H3K4me1. (A) Representative intrinsic tryptophan fluorescence spectra of CW42 in the
absence of H3K4m1 at 4–90 °C. Tryptophans were excited at 295 nm, and the emission scanned from 310 to 450 nm. Vertical lines at 335
and 355 nm indicate the wavelengths at which intensity values were the intrinsic tryptophan signal dominated by folded and unfolded
protein states, respectively. (B) Thermal denaturation profile of bound and unbound CW42. The I335 nm/I355 nm ratios derived from
fluorescence data in the presence ( ) and absence ( ) of H3K4me1 ligand were plotted vs temperature. Each data point represents the
mean of three parallels, and error bars are shown as one standard deviation where these exceed the size of the symbols. The data series
for the bound ( ) and unbound ( ) situation were then fitted (nonlinear least squares) to a 4-parameter sigmoidal expression, yielding
the midpoint of the denaturation curve, Tm, as an output in the presence ( ) and absence ( ) of H3K4me1. Inset: summary of Tm for CW42
with and without ligand bound. Error bars show 95% confidence interval of the fits in the main panel. (C) SEC-MALS elution profiles of
CW42 in the presence ( ) and absence ( ) of H3K4me1, where each profile is shown as molecular mass (kDa) vs elution time (min).
The molecular mass (gmol1) for each elution as determined by static light scattering is shown as red and blue dots for the ligand present
and absent situation, respectively. The average molecular masses for each peak are indicated (?). (D) Diffusion measurements of CW42 in
the presence (red contours) and absence (blue contours) of H3K4me1. Horizontal axes represent the projection of 1H experiments using
bipolar gradient sets separated by diffusion delays and 3-9-19 water suppression. The vertical axis is the logarithm of the diffusion
coefficient (D, m2s1). Cross-peaks represent fits of peaks extracted by fitting the 64 1H experiments to the decay function given by Eq. 3
in the Supplementary Information. Only selected peaks from the nonexchanging, upfield region were used to estimate the mean D, as
either buffer components or the ligand do not influence this spectral region. The log D value for CW42 in the presence and absence of
ligand is indicated by horizontal lines, ( ) and ( ), respectively. Representative 1D 1H spectra acquired in the presence (magenta) and
absence (green) of the ligand are shown at the bottom of the panel.
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MD simulations were performed using a representa-
tive conformation from our NMR structure, and Liu
et al.’s crystal structure. The replicates were identical
except for different initial velocities, and we find that
both structures of the complex are stable and able to
hold the ligand within its binding pocket as evidenced
by their RMSD values throughout the simulation
(Fig. 5A, Table S1). The high variations observed
from 12 to 20 ns in the RMSD values of the NMR
structure simulations are due to a displacement of the
C-terminal coil in one replicate (the C-terminal coil is
receding from the ligand). The C-terminal coil comes
back to interact with the ligand from 20 ns until the
end of the simulation. Hydrogen bond analysis of the
complex combined with secondary structure analysis




Restraints used in structure calculation Number
Total number of NOE distance restraints 1056
Intra-residual NOEs 285
Short-range, |i-j| = 1 330
Medium-range, 1 < |i-j| < 5 204
Long-range, |i-j| ≥ 5 147
Intermolecular NOEs 74
Number of upper distance limits for Zn2+ 8
Number of lower distance limits for Zn2+ 8
TALOS N ϕ/ψ dihedral angle restraints 94
Structure statistics, 20 conformers
CYANA target function value (Å2) 2.78 ± 0.22
Maximal distance constraint violation (Å2) 0.36 ± 0.04
Maximal torsion angle constraint violation 
(Å2)
0.54 ± 0.49
AMBER energies in implicit solvent 
(kcal/mol)
–3867.0074
OneDep – Ramachandran statistics
Residues in favorable regions (%) 89
Residues in allowed regions (%) 9
Residues in outlier regions (%) 2
Root mean square deviation to average coordinates (Å)
N, Cα, C’ (860–910) 0.36 ± 0.09





Fig. 3. NMR structure of the CW42-H3K4me1 complex. (A) NMR restraints and structural statistics for CW42-H3K4me1 complex. (B) The
structural ensemble of the 20 minimized NMR-derived structures, backbone Ca atoms aligned to the medoid structure, conformer 15. (C)
Strip plots for residues Q923 (HE22/NE22), I921 (HD1/CD1) and W874 (HZ/CZ) derived from the filtered-edited 3D NOESY experiments
showing intra- and intermolecular NOE connectivities to both the CW domain and the bound ligand. Graphical representations of structures
were prepared in PYMOL 1.5 (Schr€odinger, New York, NY, USA).
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both structures indicates a stable intermolecular b-
sheet (Fig. 5B). The secondary structure analysis of
the ligand in both structures shows some difference
in the residues involved in b-sheet augmentation
through the simulation (residues A2 to Q5 and T3 to
A6 of the X-ray and NMR structures, respectively,
Fig. 5C,D). The same trend has been observed in the
MD simulation replicates. These intermolecular b-
sheet interactions are reinforced by hydrogen bonds
between the ligand and the CW domain side chains.
In the crystal structure, the ligand is oriented differ-
ently for residues Q5-A7, probably due to the misori-
entation of the a1-helix (Fig. 4C). This is, in turn, a

































Fig. 4. In-solution structure of CW42-H3K4me1 complex. (A) Structural comparison of the CW42 in the free (PDB code: 2L7P, in beige) and
bound state (in light blue, PDB code: 6QXZ). The bound state is represented as the medoid structure, conformer 15. RMSD between the
apo- and holo-structures is 1.6 A. The ligand is presented in red, and the side chain of the H3K4me1 resides between W865 and W874 of
CW domain. Cartoons are rendered with 0.35 transparency setting in PYMOL to increase visibility of key elements. (B) Section of panel A,
highlighting the key C-terminal residues forming the hydrophobic pocket – I915, L919, I921 and Q923, clustering around the methylated
lysine. N916 is also indicated, but this residue does not contact the ligand. (C) Structural superposition of the CW domain in the bound state
– NMR structure (in light blue) and X-ray (in magenta, PDB code: 5YVX). The RMSD value for the core residues 863–908 is 0.913 A. The H3
residues are positioned differently in the NMR (red) and crystal structure (orange). Ligand residues Q5, T6 and A7 are indicated. The overall
backbone of the structures is similar except for the a1-helix, where Cas is displaced by about 4 A. (D) Space-fill representation of the ligand-
binding site, showing key interactions between the protein in light blue and the ligand in red. (E) As in D, but for the crystal structure,
protein in pink and ligand in orange. Graphical representations of structures were prepared in PYMOL 1.5 (Schr€odinger, New York, NY, USA).
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Fig. 5. Induction of b-sheet and rearrangement of C-terminal coil upon ligand binding. (A) Average RMSD evolution (dark colour) and standard
deviation (light colour) of the NMR WT CW42-H3K4me1 structure (orange) and crystal structure of the E917A mutant (blue) during the last
46 ns of simulations. (B) Hydrogen bond occupancy between the main chain of amino acids (aa) involved in the intermolecular b-sheet through
the last 46 ns of MD simulation performed on the NMR representative structure and the X-ray structure for each replicate (r1, r2 and r3). These
hydrogen bonds are present in the initial structures and maintained through MD simulations. (C) and (D) Secondary structure analysis of the
ligand along MD simulations performed on the X-ray structure (C) and the NMR structure (D). The results are shown for one replicate of each
structure. Points/lines indicate b-strand conformation at a given time during the last 46 ns of the MD simulation. (E) Rearrangement of the C-
terminal coil along the simulation. Snapshots from 10, 30 and 50 ns show the C-terminal coil (in red) in interaction with the ligand. The A879-
S889 coil that also shifts up to interact with the ligand is encircled in green. Graphical representations of structures were prepared in Chimera.
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and the shortened C-terminal part. Although the
sequence of the crystal structure ends at I921, just
after the a1-helix, both our affinity data for shortened
domains (CW33/37) and NMR data suggest that this
part of the domain is relevant for binding. Tellingly,
there are numerous NOE cross-peaks indicative of
stable links from this coil to both the cores of the
CW42 domain and the bound ligand (Fig. 3C). For
instance, as many as three ligand contacts are medi-
ated by I921, and six are mediated by Q923. In the
NMR structure, Q923 resides within a coil, absent in
the crystal structure, that appears as an ensemble of
fluctuating conformations. Our MD simulations indi-
cate that there is a tendency for this coil to move
towards the N-terminal part of the ligand, and
together with the g1 region interacts with the ligand
but from the opposite side (Fig. 5E). The C-terminal
coil’s rearrangement with respect to the ligand is
observed from around 10 ns and is maintained until
the end of the simulation. This observation has been
confirmed by the replicates.
Complexation modulates the flexibility of key
binding elements
Molecular motions are important for protein func-
tion in general and ligand binding in particular
[29,30]. We have observed in this study that CW42
responds to binding both at a global level and at a
more detailed level. To characterize the motional
changes triggered by binding, we compared the local
internal motions in the apo- and the holo-states of
the protein using NMR. Steady-state heteronuclear
1H-15N NOE values, and R1 and R2 relaxation rates
are sensitive to high-frequency motions (108–1012 s1)
occurring at ps-ns timescale, with R2 also having
contributions from much slower processes occurring
at µs-ms timescale [31]. The analysis of these param-
eters in the free and bound state provides informa-
tion about the protein local backbone mobility
change upon ligand binding (Fig. 6A-C). Overall, all
the residues show NOE values near 0.9, indicating
backbone motions at the ns scale. Outliers exist in
the b2 sheet, and g1 and g3 loop regions. The g1
region and the post-a1-helix flexible loop, including
Q923, undergo changes restricting motions upon
binding (Figs 4A, 6A and 5E). The R1 parameter is
generally lower for the holo-state, indicating an over-
all stabilization, while the R2 parameter shows out-
liers in the D886-R890 interval, as well as M910
and L919.
To further exploit these data, the three relaxation
parameters were combined with the structure of the
complex using the Lipari–Szabo model-free formalism
[31]. Output parameters of this analysis are the order
parameter, S2, reflecting the amplitude of the internal
motions on the ns timescale, the effective correlation
time for the internal motions, se, and the conforma-
tional exchange rate on the µs to ms timescale, Rex
(Fig. 6D-F). Overall, the order parameter values, S2,
indicate a quite flexible protein, especially for the apo-
state. Even its most stable parts have an S2 value
between 0.9 and 0.8, somewhat lower than what is
usual for folded proteins and closer to proteins with
fluctuating structures [32,33]. Differences between the
apo- and holo-states are found in the loop regions of
the protein, post-g1 in particular, but also in the b2-
sheet and the a1-helix and its posthelical coil. Overall,
the S2 values suggest a consolidation of the fold upon
binding. Residues V882-S889 of the g1 region are
restricted upon binding (Fig. 6D). The values of the
local correlation time, se, are rather low throughout
the protein (within 0.8 ns), indicating overall protein
flexibility (Fig. 6E). The Rex parameter, where avail-
able, suggests that apo-CW undergo conformational
exchange on the µs-ms timescale, often associated with
conformational shifts related to function [34]. The
majority of observed rates are below 2 s1 (Fig. 6F).
There are notable outliers, again to be found in the
b2-sheet, and near g1 and g3. These residues, with lar-
ger values than 2 s1, are R875, I877, G883, D886,
E887, D898, M910, E917, L919 and A926. For these
residues and in the a1-helix, we generally observe
higher Rex values for the apo-form, indicating a slow-
ing down of conformational fluctuations also at the
ms-µs timescales. Of these residues, only E887 and
L919 make direct contact with the ligand in at least
one of the available holo-structures, suggesting that
lock–key type formalism is not sufficient to understand
this binding process.
In contrast, binding through conformational selec-
tion may explain why we observe these outliers. Such
binding mechanisms postulate that the apo-state is flex-
ible and fluctuating and that a small population of the
bound conformation exists in equilibrium, also when
the ligand is not present [35]. When the ligand is pre-
sent, binding occurs by stabilizing the pre-organized
conformation corresponding to the bound state [36].
Although the preceding Lipari–Szabo model-free anal-
ysis implicates dynamic elements in the binding event,
the timescales associated with conformational selection
are better assessed using relaxation–dispersion NMR
experiments. In brief, this approach isolates the contri-
bution of ms-s conformational exchange towards R2
relaxation [37,38]. We performed these experiments at
600 and 850 MHz, and performed global data fits
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using the NESSY software made by Bieri et al for this
purpose [37]. In NESSY, relaxation dispersion profiles
are fitted to models identifying protein motions related
to no exchange (i.e. no movement at this timescale),
slow-exchange or the fast-exchange limit, for each resi-






CW42 residue number CW42 residue number
Fig. 6. Relaxation NMR data and Lipari–Szabo model-free dynamic analysis for CW42 in its free ( ) and bound to H3K4me1 (•) states. (A)
Steady-state 1H-15N NOEs. (B) R1 relaxation rates. (C) R2 relaxation rates. Model-free parameters derived for the free and bound states: (D)
order parameter S2, (E) local correlation time se and (F) conformational exchange rate Rex. The CW42 secondary structure is indicated at the
top of each panel. Errors are estimated by Monte Carlo simulations (CI, 95%).
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R875 n.a. n.a. M1 35.68 33.68
D886 728 412.0 M3 92.27 81.27
S889 682 141.0 M7 56.71 45.71
M894 n.a. n.a. M1 56.71 27.17
N896 531 99.2 M2 22.67 13.67
S907 16 4.3 M3 397.74 386.74
M910 18 71.9 M3 151.55 140.55
L919 1712 341.8 M2 24.57 15.57
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models using an approach avoiding overfitting based
on v2 and AICc goodness-of-fit scoring functions [39].
Examples of dispersion curves for the apo-state at
300K and 310K are shown in Fig. 7A. In the NESSY
models, Rex is an output parameter that can be inter-
preted as the contributions of relatively slow protein
motions towards the total R2 relaxation behaviour. As
the ligand binds, there is a significant (t-test, one-sided,
heteroscedastic, P < 0.05) lowering of Rex values
(Fig. 7B). We interpret this as an overall quenching of
this type of motions upon binding, a behaviour that is
expected for binding through conformational selection
[40]. For fast-exchange limit (M2) and slow-exchange
(M3) residues, tabulated examples of residues display-
ing relaxation dispersion behaviours consistent with
different models of exchange behaviour are presented
in Fig. 7C, along with extracted Kex values represent-
ing rates of conformational exchange. A plot of Kex
values for the apo- and holo-states, where residues with
large errors (more than 500 s1) removed, is presented
in Fig. 7C. All NESSY-selected models, along with
their output values and associated v2 scores, can be
viewed in Table S4 and S5.
In the following analysis, we focus on the residues
that exhibit slow exchange, as this type of behaviour is
an indication of minor populations that may be rele-
vant for binding [40]. Three residues, D886, S907 and
M910, are in slow exchange (M3), according to the
NESSY selection. D886 belongs to the g1 loop that
shifts towards the ligand upon binding (Fig. 4A), and
its actual Kex value is more similar to fast-exchanging
residues fitting the M2 model (Fig. 7C). S907 and
M910 are, interestingly, located in the g3 loop which
is known to affect binding, is fairly conserved, but also
shows ASHH2-specific variations (Fig. 1A). Because
of this, we still include S907 in our analysis even
though its associated AICc and v2 values were notably
high for S907. We also show, vide infra, that S907 has
significant (P < 0.05) effect on the binding of
H3K4me1, and abolishes binding of ligands with
K4me2 and K4me3 altogether. The rate of conforma-
tional exchange, Kex, is very slow and similar for these
two residues, around 16–18 s1 (Fig. 7C). The beha-
viour and location of the slow-exchanging residues in
the g3 loop which leads up to the a1-helix (Fig. 7E) is
suggestive of a mechanism where the flexibility of the
loop allows the a1-helix to sample the binding confor-
mation, which is then consolidated if the correct ligand
is present.
The coils flanking the a1-helix are mediators of
binding and flexibility
The findings presented above are consistent with a role
for protein conformational sampling in binding. We,
therefore, returned to our MD simulations and com-
pared the root mean square fluctuation (RMSF) and
the radii of gyration (Rg) of the bound and unbound
states. In the simulations, the Rg values of the apo-
state and holo-state overlap at a time, suggesting that
the apo-state can sample the bound conformation
(Fig. 8A). RMSF calculations remove the time dimen-
sions in the simulations and allow this measurement
for local flexibility to be plotted onto the domain
backbone. Overall, the domain fluctuates from 50% to
30% less in the bound form than in the free form
(Figs 8B and S3A). The g1, g2 and g3 regions where
molecular rearrangement takes place upon binding
appear as outliers with increased and unaffected flexi-
bility. The MD and NMR dynamics data generally
match; both approaches indicated a restriction of the
holo-structure as well as showing outliers in the same
regions. Both results corroborate the initial low-resolu-
tion characterization of ligand binding (Figs 1 and 2).
Our simulations also indicate a difference between
the two holo-structures as determined by NMR and
Fig. 7. The ms dynamics of CW. (A) Examples of relaxation dispersion data accumulated at 600 MHz and 850 MHz field strengths (at 300
and 310K), and then globally fitted in NESSY by Monte Carlo simulation. The fitting procedure attempts to fit three models and is selected
using v2 and AICc tests measuring the goodness of fits. The models M1-M3 allowed are no exchange (M1), two states in the fast-
exchange limit exchange (M2) and two states in slow exchange (M3). (B) Box plots of the apo- and holo-distribution of all Rex output values
found by the NESSY fits. Circles designate outliers, whiskers are the highest and lowest nonoutlier values in the data sets, and upper and
lower box border is the third and first data quartile, respectively. The data median is indicated by the black bar. Mean values when outliers
are removed are 3.1  0.64 rads1 and 2.0  1.55 rads1 for the apo- and holo-situation, respectively. The difference between the two
data sets is significant (P < 0.05, Student’s t-test, one-tailed, heteroscedastic). (C) Examples of extracted Kex values from fits performed by
NESSY, along with the model selected and their v2 and AICc scores. Errors are estimated by Monte Carlo simulations (CI, 95%). (D) Plot of
determined Kex values for the apo- and holo-forms of CW42. Values with errors exceeding 500 s
1 are not included in this plot. (E) Kex
values associated with the apo-state plotted onto the unbound NMR structure of CW (2L7P). Residues with quicker motions are drawn
using thicker stick representation and more intense red colour. Residues exhibiting slow-exchange behaviour are indicated in yellow and
thinner stick representation. For full, tabulated summaries of NESSY output, see Table S4 and S5. The graphical representation of the
structure was prepared in PYMOL 1.5 (Schr€odinger, New York, NY, USA).
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crystallography. However, it was unclear whether this
is caused by the inherent differences in the crystal vs
the NMR model, or whether the sequence difference is
the cause. We, therefore, modified the NMR-structure
sequence in such a way that it matched the crystal
structure sequence (Fig. 8E), and simulated these two
states for 50 ns. The method used to resolve the struc-
ture does seem to impact the complex flexibility since
the NMR structure fluctuates much more than the
crystal structure during MD simulations (30–50%
more, Figs 8C and S3B). This suggests that Liu et al.
structure is restricted to a very limited conformational
space.
The truncation of constructs scored for H3Kme1
binding affinity indicated that removing the C-terminal
adversely affects binding affinity (Fig. 1, constructs
CW33 and CW37). The NMR data and MD simula-
tions also supported a role for the C-terminal post-a1-
helix coil in binding (Figs 6A,D and 5E). To evaluate
the impact of this part of the sequence on the complex
flexibility, we compared the RMSF of the complex with
and without the C-terminal coil (for a schematic over-
view of how structures are compared, see Fig. 8E). The
results indicate a high (DRMSF ≥ 50%) and a moderate
(30% < DRMSF < 50%) increase in flexibility in the
NMR structure lacking the C-terminal coil, residing in
the a1-helix and b-sheet, respectively (Figs 8D, S3C). In
contrast, the g1 and g2 regions experience a stabiliza-
tion upon removal of the C-terminal coil. Moreover, the
ligand is not stable within the binding site of the trun-
cated structure simulations, underlying the importance
of the C-terminal coil for the ligand stability. Neverthe-
less, the ligand is stable in the X-ray structure simula-
tions and in the comparative simulation with its NMR
counterpart (see Fig. 8E schematics), suggesting that
the E917A mutation plays an important, albeit artificial,
role in the complex stability.
Our structural and dynamics results, as well as
sequence alignment and earlier work, strongly impli-
cate the g1 and g3 loops. A graphical summary of this
is presented in Figs 1A and 9A. g3 notably contains
conserved residues with variation relatable to the loop
flexibility, such as Pro to Ser variations. The holo- or
apo-structures do not show much difference in these
places (Fig. 4A), yet the conservation pattern and the
MD and NMR results related to mobility suggest that
these residues might be involved in regulating the equi-
librium position of the a1-helix in the free and bound
situation. An effect on H3K4me1 binding, or ability to
differentiate between methylation states, would be par-
ticularly interesting since these residues are in a coil
without directly contacting the ligand, and the back-
bone trace of the apo- and holo-forms is essentially the
same (Fig. 4A).
We note that Hoppmann et al. mutated two residues
in this region, Q908A and E909A, and both mutations
effectively abolished binding in pull-down assays ([8]
and Fig. 9A). In reference to this work and our cur-
rent dynamics data (derived from NMR, as well as the
RMSF analysis), we further probe the involvement of
S907 and Q908 in modulating the binding affinities of
H3K4me1-3 using Isothermal calorimetry (ITC). For
unmutated CW42 interacting with H3K4me1, the
binding constant and stoichiometry of interaction were
determined to be Kd = 1.09  0.21 µM and n = 0.85 
0.05, respectively. The reaction is enthalpy-driven (DH
of 91.63  8.14 kJmol1), while the DS term is neg-
ative (DS = 192.98  25.97 Jmol1K) (Fig. 9B-D),
in support of the net ordering of the complex reported
above. Since the Q908A polar to aliphatic mutation
has already been performed by Hoppmann et al., we
did a structurally conservative Q908E mutation that
converts this polar residue into a charged one. This
results in a 17-fold drop in affinity (Fig. 9B, C,
Fig. 8. The flexibility of the domain is influenced by ligand binding and the posthelical coil. (A) The calculated radius of gyration (A) as a
function of simulation time for the apo (orange)- and holo (blue)-forms of ASHH2 CW for one of the MD simulation replicates (n = 3). The
lighter colours show the radii of gyrations, and the darker line (univariate spline curve) highlights their overall trend. (B, C, D) Comparative
flexibilities of CW structures. Relative changes in flexibilities are calculated by comparing the RMSF values of a given state to a reference
state (per cent change). For all panels, cyan to blue colours represent parts of the complex that are less flexible than the reference state.
Yellow to red colours represent the parts of the complex that is more flexible than the reference state. For the extreme red and blue
colours, the |DRMSF| ≥ 50%. The results are shown for one replicate of each state. (B) RMSF differences between the apo-state as the reference vs the
holo-state of CW42, using the NMR structures available. Structures used were 2L7P and 6QXZ, modified to match in length, and see panel E. The ligand
is represented in light green. (C) RMSF differences between the holo-form crystal structure (mutant) as the reference state vs the NMR holo-form NMR
structure. Structures used were 5YVX and 6QXZ, where the latter NMR structure also has been modified with the E917A mutation and a shortened the
C-terminal coil to match of the 5YVX structure, and see panel E. (D) RMSF differences between the full-length NMR apo-complex as the reference state
vs the same structure without the C-terminal coil. Structures used were 6QXZ, and a version where the latter has the C-terminal coil removed, and see
panel E. In this last case, the ligand is not stably locked in the binding site and is therefore not shown. (E) Schematic overview of the structures used in
panels B, C and D. The blue triangle indicates the crystallization mutant E917A. The reference model referred above is indicated by REF. Graphical
representations of structures were prepared in Chimera.
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P << 0.01). For S907, we note that Ser is an amino
acid associated with a high amount of flexibility, only
surpassed in this regard by Gly according to amino
acid flexibility rankings [41]. We, therefore, mutated
this residue to confer both higher (S907G) and lower
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and observed that affinity was lowered somewhat. For
the restricting S907P mutation, Kd increased almost
threefold from 1.09  0.21 µM to 3.22  0.29 µM (t-
test, P < 0.05), while S907G resulted in no significant
increase (1.80  0.51 µM). However, when we also
investigate the ability of H3K4me2 and H3K4me3 to
bind these mutations, we were unable to produce bind-
ing isotherms, suggesting that these flexibility-modulat-
ing mutations are involved in allowing CW to
differentiate between methylation states (Fig. 9E,F). In
contrast, the D886A mutation, positioned in the g1
loop that moved towards the ligand upon binding in
the structure (Fig. 4A), does not affect H3K4me1
binding much (Fig. 9C) and is still able to bind
H3K4me2 at reduced (~ 5-fold) affinity (Fig. 9E).
To examine the effect of the post-C-terminal coil on
binding, we also designed a Q923A mutant, which
formed NOE contacts with the ligand (Fig. 3C), and
performed ITC. These affinity measurements showed
that the mutant destroyed specific binding, making it
impossible to produce reliable isotherms (Fig. S2), con-
firming the importance of this residue for binding. We
also investigated the effect of altering the H3 peptide.
Beyond the central K4me1, the importance of residues
1–3 has been determined by Liu et al. [14]. However,
the structure presented here suggests that T6 is
involved in specific contacts with the ligand site,
including L919 and W865 (Fig. 4D). When performing
a T6A amino acid substitution in the H3K4me1 pep-
tide, ITC measurements failed to produce reliable
binding isotherms (Fig. S2). It may also be relevant
that H3 can be phosphorylated at T6 [42]. Such a
PTM modification would destroy complementarity
(Fig. 4D), and likely abolish binding.
Discussion
Several low-resolution techniques used to assess CW42
to H3K4me1 interaction suggested that a reorganiza-
tion, compaction and overall slowing down of
dynamics takes place upon binding. However, only a
limited amount of reorganization was apparent when
comparing the apo- and holo-structures. Investigation of
the dynamic behaviour of the bound and unbound
states using NMR and MD provided a more compre-
hensive picture. The apo-state is relatively flexible on the
ns timescale (Figs 6A,D and 8B), with several hotspots
(g1 and g3) also showing tendencies for dynamics on
the µs-ms timescale (Fig. 6F). Using relaxation disper-
sion experiments, we were able to extend our view of the
domain’s dynamics to the ms-s timescale, where in par-
ticular the g3 loop displayed indications of concerted
slow exchange at a rate of about 16–18 s1 (Fig. 7C).
Significantly, g3 mutations at the S907, Q908 and E909
positions adversely affect binding, especially for
H3K4me2 and H3K4me3 (Fig. 9E,F). The MD simula-
tions exhibit a variation in the apo-form’s RMSD across
the simulation that is consistent with a dynamic loosen-
ing and compaction of the structure at equilibrium.
Although each replicate spans 50 ns only, the repeats all
show the same tendencies, and the NMR dynamics
spanning ns-ms timescales corroborate this. In sum, this
suggests that the equilibrium apo-state is less compact
than determined structures indicate, and may sample a
compact, less flexible holo-state.
Compaction behaviour like this has been linked to
disorder–order transitions [43]. Our ITC data show that
there is a significant entropic cost (192 Jmol1K)
associated with binding. The entropic cost must be at
least partially related to ordering of flexible elements, as
ligand binding should lead to entropically favourable
desolvation of the hydrophobic residues of the ligand
and the binding pocket. While the apo-state of CW is
certainly folded, there are enough mobile elements for a
disorder-to-order transition to occur. Such binding-in-
duced ordering events are relatable to both induced fit
and conformational selection mechanisms of binding,
where two fairly flexible entities mutually explore con-
formational space conductive to binding [35,40]. The
availability of these states at ambient conditions is
Fig. 9. Mutants in coils and their effects on the binding properties of the CW42-H3K4me1 complex. (A) Ribbon representation of the CW42-
H3K4me1 complex. The ligand is shown as sticks in red; mutated residues in this study and Hoppmann et al. study are shown in element-
specific colouring. There are no direct contacts between the mutated residues and the ligand, except for Q923. The graphical representation
of the structure was prepared in PYMOL 1.5 (Schr€odinger, New York, NY, USA). (B) Representative ITC data interacting with H3K4me1. Top
panel displays representative corrected heat rates plotted against time for CW ( ) and the CW Q908E mutant ( ) titrated against the
ligand. The bottom panel represents the normalized peak areas (CW, •; Q908E, ▪) plotted vs the ligand/protein mole ratio. (C) Bar plot
representation of mean Kds where error bars represent one standard deviation (n = 3). Statistical significance of pairwise differences as
indicated (t-test, *, P < 0.05, **, P < 0.01). (D) Derived thermodynamic parameters for CW42 and mutants binding to H3K4me1. All values
are averages based on three determinations, with errors given as standard deviations. N is the binding stoichiometry. (E) Derived
thermodynamic parameters for CW42 and mutants binding to H3K4me2. All values are averages based on three determinations, with errors
given as standard deviations. N is the binding stoichiometry. (F) Attempts to determine binding and thermodynamic parameters for CW42
mutants binding to H3K4me3 failed after the indicated number of parallels.
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related to both the folding behaviour and flexibility of
the protein [44], and both NMR and MD data all point
towards CW42 having sufficient flexibility to populate a
spectrum of conformations at timescales ranging from
ns to ms (Figs 3B and 6-8). For the g3 region, we also
find limited evidence that the apo-CW exchanging beha-
viour samples the same state. Throughout these analy-
ses, the g1 and g3 coils consistently display interesting
behaviour, and residues therein also show effects on
CW binding behaviour when mutated. Taken together,
this is consistent with a CW binding behaviour that is
suggestive of conformational selection.
There also appears to be an element of induced fit
[45], where equilibrium in the bound states of both the
ligand and CW42 is shifted towards new structural ele-
ments, most notably the b-sheet augmentation observed
in the MD simulations (Fig. 5). In addition to the con-
tacts made by the side chain of K4me1, b-sheet augmen-
tation may help dictate the ligand sequence specificity
towards the ASHH2 CW domain, as is the case for a
number of other instances [46]. The side chains of R2,
K4me1 and T6 all orient towards CW42 in the b-sheet
and contribute to the final complementarity of the
bound state by intercalating as shown in Fig. 4. Con-
versely, T3, Q5 and A7 are oriented away. This recogni-
tion, based on the alternating orientation of side chains,
is similar to that reported for the MORC3 CW domain,
where b-augmentation is also part of the binding mech-
anism [21]. Yet, these zipper-like fits are not enough for
recognition and binding, as the unmethylated ligand
will not bind. Conformational selection may offer an
explanation. A lack of or incorrect methylation on K4
will not trigger b-sheet augmentation, and therefore, the
zipper-like complementarity will not arise from the
ensemble of conformations. The mediator of this could
be changes in the a1-helix equilibrium position over the
K4me1 side chain, mediated by the g3 loop, followed
by rearrangement of coils (the g1 and the C-terminal).
In particular, the g1 loop, although fitting models for
slow exchange in the relaxation dispersion analysis
(Fig. 7B), displays quite fast dynamics, and the D886A
mutation is not as crucial for binding of the methylated
ligands (Fig. 9). One interpretation of this would be
that the first step of binding is mediated by the slowest
category of exchange, related to g3 and a1-helix
dynamics, and is followed by a more rapid consolida-
tion step mediated by the g1 loop.
Our mutation studies on the coils flanking the a1-he-
lix do show that it is possible to affect binding without
directly contacting the ligand or the binding site. Since
coils are flexible entities, this suggests that they play the
role of tensile regulators of the complementary fit
between the ligand, and I915, L919 and Q923. As far as
we know, the involvement and functional importance of
flexibility in recognizing and binding histones has not
been suggested before for CW domains. There are, how-
ever, relevant precedents in the literature. Functional
flexibility has been reported for acetyltransferases acting
on histones [47], as well as bromo-domains binding such
acetylation sites [48]. Flexibility and fluctuating confor-
mations may shed light on how ASHH2 CW differenti-
ates between methylation states while at the same time
effectively searching the histones. Conformational selec-
tion and induced fit mechanisms have been reported to
be important for search and dock tasks, such as effec-
tively scanning DNA for sequence-specific DNA methy-
lations [49]. Being able to sample a range of similar
PTM states along histones tails before settling down
and activating the full enzyme, rather than locking
down at the first favourable interaction, would be an
attractive property for any protein acting within the
complex environment of chromatin.
Although this study concerns the properties of the
CW domain, it is relevant to also discuss results in the
context of the function of the full-length multidomain
ASHH2 protein. Conformational selection is also
implicated in regulation mechanisms [35]. Although a
speculation, the CW domain could act not only as a
passive reader that docks the full enzyme correctly but
also play a role in activation and regulation. Extrapo-
lating from the CW structure presented here suggests
that the domains of C-terminal from CW are oriented
away from H3; however, the movement of the C-ter-
minal of CW also suggests that a rearrangement takes
place that could position the SET domain optimally.
The b-augmentation could stiffen both CW and the
H3 tail as part of this positioning. Our study, although
restricted to the ASHH2 CW domain, suggests that
protein flexibility, as well as conformational selection,
plays an active role in the function of the ASHH2 CW
domain. Future work on the structural biology of both
nucleosome and chromatin remodellers would benefit
from employing a theoretical framework and method-
ology that allow for the detection and assessment of
functional disorder and flexibility.
Material and methods
Materials
The H3 tail mimicking peptides were synthetized by LifeTein
(H3K4me1, ARTKme1QTARY). For NMR samples, the
peptides were also synthesized with specific stable isotope
labelling sites as follows: A(15N,13C)RTKme1QTA(15N,13C)
RY; AR(15N,13C)TKme1QTARY; and ARTKme1QTAR
(15N,13C)Y. All peptides had 95% purity as assessed by mass
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spectrometry. D2O,
15N-enriched (99%) NH4Cl and
13C-en-
riched (99%) glucose were purchased from Cambridge Iso-
tope Laboratories, Inc. (Tewksbury, MA, USA), and SVCP-
Super-3-103.5 NMR tubes were acquired from Norell Inc.
(Morganton, NC, USA). Unless otherwise specified, samples
were buffered by the T7 solution (25 mM Tris/HCl pH 7.0,
150 mM NaCl, 1 mM TCEP). Buffer components were
acquired from Sigma-Aldrich. CW constructs were prepared
using ligation-independent cloning in the KpnI/SacI restric-
tion sites of pET-49b vector (Novagen/Merck, Darmstadt,
Germany), and the protein and all mutants were expressed
and purified as described [24]. For more details, see Support-
ing Information: Cloning of CW constructs, site-directed
mutagenesis, protein expression and purification. Protein
and peptide concentrations for all types of samples were
determined using UV-Vis spectroscopy (NanoDrop: absorp-
tion at 280 nm, extinction coefficient 19730 M1cm1 for
CW constructs, 1490 M1cm1 for H3K4meX peptides).
Intrinsic tryptophan fluorescence
Affinity measurements
The approach for determining Kds was adapted from Ref.
[50,51] and is further described in Supporting Informa-
tion: Intrinsic tryptophan fluorescence affinity measure-
ments. Briefly, for each combination of CW construct and
H3K4meX, a titration with constant protein concentration
and variable ligand (typically 0.0–8.2 µM, up to 15.9 for low-
affinity binders) concentration was performed. Stocks were
prepared so that the cuvette concentrations for parallel runs
always were within 2.0–2.4 µM. The intrinsic tryptophan flu-
orescence was monitored at wavelengths where the intensity
response was greatest in each case (typically 319–322 nm).
D-intensity values at the wavelengths where the protein-only
contribution is subtracted were used as the observable, FPL,
when the dissociation constant Kd was determined using a







FP and FPL are fluorescence of the protein and protein–
ligand complex, respectively, while Po and Lo are the total
concentrations of the protein and the ligand. The shape of
the curves, rather than the absolute measurement values,
affects the Kds, which was determined at least three times
for each CW construct–ligand combination. Final affinity
values and their errors are means of these determinations,
and their standards deviations, respectively.
Thermal denaturation measurements
The ratio of the fluorescence intensities recorded at 335 and
355 nm as a function of temperature was monitored. This
ratio is a useful proxy for measuring the unfoldedness of a
protein [25] and can be used to fit a 4-parameter sigmoidal
curve with Tm as an output parameter. For each sample and
temperature point, data were acquired from 310 to 400 nm,
and temperature ranged from 4 to 90 °C (5–10 °C stepwise
increases). Between each measurement, a 5-min wait was
introduced for thermal equilibration. The 100-µL quartz cuv-
ette was equipped with a lid to prevent sample evaporation.
For more details, see Supporting Information: Thermal
denaturation monitored by intrinsic tryptophan fluorescence.
NMR spectroscopy
Data collection
Data were collected at 25 °C on an 850 MHz Bruker
Avance III HD Spectrometer fitted with a 1H/13C/15N TCI
CryoProbe and a SampleJet with temperature control for
storing samples in between runs (set to 4 °C). Samples were
prepared in NMR buffer consisting of 20 mM potassium
phosphate, 50 mM NaCl and 1 mM DTT adjusted to pH
6.4, and all NMR experiments related to the backbone and
side-chain assignment performed for this study (summa-
rized in Table S2) were collected, processed and analysed
as described previously [24]. Protein diffusion measure-
ments were performed on protons at 25 °C using stimu-
lated echo, bipolar gradients and 3-9-19 pulse train for
solvent suppression. 1H-15N NOE values, and 15N longitu-
dinal (R1 = 1/T1) and transverse (R2 = 1/T2) relaxation
rates were acquired using sequences in Table S2. Local
backbone dynamics was determined using model-free
Lipari–Szabo formalism. CPMG relaxation dispersion
experiments were acquired at 600-and 850-MHz fields at 25
and 35 °C using pulse sequences, series of spin-echo pulse
elements and relaxation delays described in Table S2. Anal-
ysis of the relaxation data was carried out in Bruker
Dynamics Center 2.5.3 (Bruker BioSpin, Billerica, MA,
USA) and NESSY [37]. For more details, see Supporting
Information: Heteronuclear NOE, relaxation measurements
and Model free analysis of backbone local dynamics.
Structural calculation, refinement and validation of the
CW42-H3K4me1 complex
Assignment of ARTKme1QTARY in complex with CW42
was carried out using 2D-filtered 1H-1H TOCSY and 2D-fil-
tered 1H-1H NOESY spectra. The peptide assignment was
used to establish the intermolecular NOE connectivities with
CW42 (BMRB ID: 27251, [24]). Intra- and intermolecular
NOE cross-peaks were assigned manually using the CARA
program v 1.9.1.2 [52]. The structure of the CW42-H3K4me1
complex was then calculated using CYANA v. 3.97 (L.A.Sys-
tems, Inc.,Tokyo, Japan) [53] , based on distance constraints
converted from the NOESY peak lists and torsion angles
obtained from the secondary chemical shifts in TALOS N
[54]. Two hundred conformers were calculated using
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CYANA with 15 000 simulated annealing steps. To ensure
that the Zn2+ ion tetrahedral geometry was correctly repre-
sented, the position of the Zn2+ ion was restricted towards
the final stage of calculation by setting the lower and upper
distance limits for Sc-Zn2+ to 2.2 and 2.4 A and to 2.9 and
3.4 A for Cb-Zn2+ for the residues C868, C871, C893 and
C904. The twenty structure conformers of the complex with
the lowest target functions were subsequently energy-mini-
mized in implicit solvent (Generalized Born [55]). This was
done using the Amber ff14SB force field [56], with modifica-
tions for the monomethylated lysine [57] and ZAFF parame-
ters for Zn2+ and the Zn-coordinated amino acids [58]. The
procedure consisted of 50 000 steps of steepest descent fol-
lowed by 10 000 steps of conjugate gradient minimization
with a 100 nm cut-off for nonbonded interactions. NOE con-
straints were applied as a square well potential with a force
constant of 50 kcalmol1A2. The refined conformations
of the CW42-H3K4me1 complex were validated in RCSB
validation server OneDep [59] and deposited as PDB entry
6QXZ. For more details, see Table S2.
Molecular dynamics simulations
Molecular dynamics simulations were performed on the fol-
lowing four structures: a representative conformation of the
CW42-H3K4me1 complex of the NMR structure reported
in this work (PDB ID: 6QXZ, ‘NMR full’); the crystal
structure complex (PDB ID: 5YVX); the uncomplexed
NMR structure (PDB ID: 2L7P); and the CW42-H3K4me1
complex again, but with the E917A mutation specific to the
crystal structure and with the C-terminal removed (residues
G922–A928, ‘NMR Cut’). The latter simulation was per-
formed to evaluate the relevance of these differences and to
be able to compare simulations with the same number of
atoms. For the NMR structures, residues related to the
plasmid or peptide design, and thus not native to the
sequence, were removed in the N-terminal prior to simula-
tion. Briefly, the structures were subject to 50-ns MD simu-
lations using NAMD and the CHARMM36 force field [60–
62]. In order to obtain a better sampling, a total of three
simulations have been run for each system, using different
initial velocities. Each system was solvated with TIP3 water
molecules and neutralized with chloride and potassium ions
using CHARMM, and then energy-minimized prior to
three equilibration steps: water simulation with constrained
structure (100 ps), simulation with protein backbone and
key ligand-binding residues constrained (500 ps), and
unconstrained simulation prior to main simulation
(500 ps). For details of the equilibration steps, see Support-
ing Information: Molecular Dynamics Simulations.
Isothermal calorimetry
Isothermal calorimetry was performed for the wild-type
(WT) CW42 and the mutants at a stirring rate of
300 r.p.m. at 25 °C. The protein concentrations of CW42
and the mutants were typically in the range of 50–180 µM,
and the enthalpy of binding was determined by stepwise
titration with 400–1800 µM histone peptide (H3K4meX,
ARTKmeXQTARKY, where X denotes the number of
methyl groups on the lysine, 1–3). Both the protein and the
peptide were dissolved in T7 buffer, and the heat of peptide
dilution into T7 buffer was subtracted from the measure-
ment using the average of 22 successive titrations. Cor-
rected heat flow peaks were integrated, plotted and fitted
by independent modelling to determine binding parameters
using the NanoAnalyze V 2.4.1 software. Experiments were
performed in triplicate or more on a Nano ITC from TA
Instruments.
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HHHHHSAALEVLFQGPG where the sequence in bold is the GST-tag and in italics is the HRV 3C 
cleavage site) and subsequently cloned into pSXG vector was subjected to site directed mutagenesis with 
PCR. For forward and reverse primers used in this process, see Table S3. After the PCR reaction and DpnI 
enzyme treatment, linearized DNA was ligated in a reaction mixture containing the PCR product, NEB4 
buffer, T4 ligase, PNK T4 Kinase, 1 mM ATP and 10 mM DTT (room temperature, 20 minutes). 
Chemicompetent One Shot TOP10 cells were transformed with ligated plasmids. The mini-prep plasmids 
obtained were verified by sequencing. The mutant CW42-constructs were then expressed as GST fusion 
proteins in BL21-CodonPlus (DE3)-RIL chemicompetent cells.  
Intrinsic tryptophan fluorescence affinity measurements 
Each experiment was performed as follows: 100 µL of CW33, CW37, CW42 or CWs dissolved in T7 
buffer was placed in a cuvette (protein concentration 2.2 µM) and then 2 µL aliquots of histone peptide in 
T7 buffer (~40µM histone peptide, and also 2.2 µM CW) were added. This ensured that the CW 
concentration was constant at 2.2 µM throughout all titrations. Typical titration series consisted of 9-12 
concentration points in the range of 0.0 - 6.2 µM for the H3K4me1 peptide titrated into all CW constructs. 
Similar concentration values were used for H3K4meX peptides. This usually gave final protein:peptide 
concentrations of up to 3.3, enough to reach saturation for the high-affinity instances. For the weaker binding 
proteins, larger aliquots were added. A total of 13 unique titration series were performed, one for each CW 
in combination with H3K4m1, H3K4me2 and H3K4me3, plus one where CWs was titrated with H3K4me0. 
The CWs to H3K4me0 titration indicated that no binding took place, and so H3K4me0 binding was not 
investigated further for the other constructs. Each series was prepared from stocks and repeated up to three 
times, to ensure repeatability. Intrinsic tryptophan fluorescence data was acquired for each unique series 
and its repeats on a Jasco FP-8500 Series Fluorimeter at 25 °C. Tryptophans were excited at 290 nm, and 
emission data was recorded in the interval 300-450 nm. Representative blanks consisting of histone peptide 
only titrated into T7 buffer were also acquired and subtracted prior to further analysis. Intensities, FOBS, at 
the wavelength giving the largest fluorescence change (typically in the interval 319-322nm) were recorded 
as a function of histone peptide concentration. Then, the dissociation constant Kd was determined using a 
non-linear least-squares fit to this equation. ���� = ���� + (��� − ��) × �((�� + �� + ��) − (�� + �� + ��)2 − 4����)1/2�   Eq. 1 
2 
 
Here, FP and FPL are fluorescence of the protein and protein-ligand complex, respectively, while Po and 
Lo are the total concentrations of the protein and the ligand. The fitting procedure also includes the option 
for fixing individual parameters at known values and also a factor that can be used to assess the effects of 
errors in the ligand concentration. Data was fit for each individual parallel, rather than averages of parallels; 
Kds provided in the Fig. 1D in the main document are averages of at least three such fits, and the errors 
given are one standard deviation. Examples of individual data fits are shown in Fig. 1C in the main 
document, and in Fig. S1 in this document. 
Thermal denaturation monitored by intrinsic tryptophan fluorescence 
The three tryptophan residues in the CW domain were excited with a 295 ± 2.5 nm light beam in an 
LS 50B Fluorescence Spectrometer, and using a 100 µL quartz cuvette to hold the sample. Fluorescence 
was observed between 310 nm and 450 nm with a scanning rate of 100 nm/min, and each measurement was 
an average of 5 scans. Experiments were performed in triplicates with and without 5 times molar excess of 
H3K4me1 peptide. Before each experiment, the samples were spun down at 17000 x g for 30 minutes to 
ensure that any precipitates were removed, and protein concentration (typically 5-15 µM) was measured 
after this step. Each sample was subjected to a temperature gradient ranging from 4 °C to 90 °C, using a 5 
°C – 10 °C stepwise increase in temperature. Between each temperature increase, 5 minute waiting intervals 
were introduced for the sample and holder to reach thermal equilibrium. The cuvette was equipped with a 
lid, to prevent evaporation from the sample. Fluorescence data measured from the blank (T7 buffer at 4 °C) 
was subtracted, and the ratio of the fluorescence intensity at 335 nm (dominated by tryptophan fluorescence 
of a folded domain) and 355 nm (representative of a tryptophan exposed to the solvent) was plotted against 
temperature. This parameter, I335nm/I355nm, is a useful proxy for the overall fold of the protein (1). A 
global curve fit using a 4-parameter sigmoidal curve taking all parallels into account was then used to find 
the Tm:  �(�) =  �0 + ��1+10�−��−�� �     Eq. 2 
Here, y0 is the slope of the pre-transition state, yf is the slope of the post-transition state, Tm is the 
inflection point in the curve, and b is the slope at the inflection point. 
Determination of molecular weight by multi-angle static light scattering 
Analytical size exclusion chromatography was performed by injecting 100 µl of either CW42 at 450 
µM or CW42 at 450 µM with a 2-fold molar excess of H3K4me1 peptide onto a Superdex 75 10/300 
Increase column (GE Healthcare) connected to an Äkta Purifier (GE Healthcare). The running buffer was 
T7 and the flow rate was 0.4 ml/ml. The Äkta system was connected to a mini-DAWN TREOS multi-angle 
static light scattering (MALS) detector (Wyatt) and an Optilab rEX differential refractometer (Wyatt) for 
absolute molecular weight determination. The molecular weights were determined using the ASTRA 
software (Wyatt).  
Protein diffusion measurements:  
Stimulated echo 1H NMR diffusion measurements using bipolar gradients and 3-9-19 water 
suppression were performed at 25 °C. Briefly, 64 gradients arranged in a linear gradient ranging from 5% 
to 95% of the maximum strength were recorded as pseudo-2D NMR data. The number of scans were set to 
8, and the gradient pulse duration and diffusion time were set to 1000 µs and 300 ms, respectively. Each 1D 
slice was processed using 2k data points, a squared cosine window function for FID apodization, and qfil 
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baseline modification. The resulting traces were then phased and subjected to a 5-term polynomial baseline 
adjustment prior to processing using the Bruker AU-program dosy2d. The program finds the diffusion 
constant, D, by fitting the decaying signals of each peak (picked using automated peak picking) to:  � = �0�−(���)2�Δ�−�3−�2��  Eq. 3 
Here, I and I0 are the volumes in the presence and absence of gradients, γ is the gyromagnetic ratio of 
1H, G is the gradient strength, δ is the duration of the bipolar gradients and τ is the gradient recovery time. 
∆Τ is a constant described as the sum of the diffusion time ∆, δ and 2τ. Only selected peaks from the non-
exchanging, upfield region were used to estimate the mean diffusion constant, as either buffer components 
or the ligand do not influence this spectral region. The Stokes-Einstein equation, Eq. 4, was then used to 
calculate the hydrodynamic radius of holo and apo CW. 
 � = ���6���   Eq. 4 
In Eq. 4, D is the diffusion constant of a rigid sphere in solution, kB the Boltzmann constant, η the 
viscosity of the solution and R is the radius of the assumed sphere. 
Assignment and structure calculation of the CW42-H3K4me1 complex:  
The ARTKme1QTARY peptide in complex with CW42 was assigned using 2D filtered 1H-1H TOCSY 
(mixing times of 40 ms, 80 ms, 120 ms) and 2D filtered 1H-1H NOESY spectra (50 ms, 80 ms, and 120 ms 
mixing time) (Table S2). This assignment was then used to establish the intermolecular NOE connectivities 
with CW42 (BMRB ID: 27251, [1]). Intra- and intermolecular NOE cross-peaks, based on data collected 
on labelled CW42 samples in complex with unlabelled peptide, were assigned manually using CARA 
program v 1.9.1.2 [2] using the experiments detailed in Table S2. Additionally, a set of 2D 1H-15N/13C - 
HSQC’s and 3D 15N/13C - edited NOESY-HSQC spectra were collected for the samples containing 
unlabelled CW42 bound to H3K4me1 with selectively 13C- and 15N-labelled residues (A1, A7, R2, and R8, 
see Table S2). Intensities of the NOE cross-peaks were integrated using the model-based linear equation 
system method [2] and exported as NOESY peak lists into the torsion angle dynamics program CYANA v. 
3.97 [3]. Torsion angles were obtained from the secondary chemical shifts using TALOS N [4].The structure 
of the CW42-H3K4me1 complex was then calculated based on the distance constraints converted from the 
NOESY peak lists and the TALOS N derived torsion angles. The monomethylated lysine residue was 
defined in silico using the UCSF Chimera package, based on a modification of the standard lysine residue 
from CYANA library [5]. 200 structures were calculated using CYANA with 15 000 simulated annealing 
steps using the distance and dihedral angle restraints. 
Heteronuclear NOE, relaxation measurements and Model free analysis of backbone 
local dynamics 
In order to perform model-free NMR analysis, 1H-15N NOE values, 15N Longitudinal (R1 = 1/T1) and 
transverse (R2 = 1/T2) relaxation rates were acquired using sequences in Table S2. For determination of 
heteronuclear NOEs, two 1H-15N HSQC data sets were recorded. A recycling delay of 10 s was used between 
transients. T1 measurements were based on inversion-recovery type experiments recorded using 11 different 
delays: 20, 60, 80, 100, 200, 400, 600, 800 (performed twice), 1000, 1200, and 1400 ms. T2 measurements 
were carried out using a Carr-Purcell-Meiboom-Gill (CPMG, [6]) spin-echo pulse sequences acquired with 
12 different delays: 16, 30, 60, 95, 125, 160, 190, 220, 250, 345, 440, and 500 ms. Recycle delays of 10 s 
were used in both experiments.  
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1H-15N steady-state NOE, longitudinal relaxation rate R1 (1/T1), and transverse relaxation rate R2 (1/T2) 
were determined from cross-peak intensities/integrals in 1H-15N HSQC spectra. The heteronuclear NOE 
values were estimated as the ratio of the steady-state intensities measured in the presence and absence of 
saturation of the proton magnetization. R1 and R2 parameters were obtained by fitting the peak intensities 
acquired at different relaxation delays to a two-parameter (I0, and T1 or T2, respectively) exponential decay 
function, using a nonlinear Levenberg-Marquard algorithm. The errors of the fitted parameters were 
estimated from the inverse of the weighted curvature matrix, using a confidence level of 95%. In all cases, 
the uncertainty on the intensities was estimated from the standard deviation of the noise in each spectrum. 
Analysis of the relaxation data to determine local backbone dynamics was performed using Model-free 
Lipari-Szabo formalism [7], carried out in Bruker Dynamics Center 2.5.3 (Bruker BioSpin).  
CPMG relaxation dispersion spectra were acquired at 600 MHz and 850 MHz, as a series of pseudo-
3D experiments using constant CPMG period (TCPMG) of 0.04 s and 0.08 s, respectively. The following 
CPMG field strengths, υcp, were used: 25, 50, 100, 150, 200, 250, 300, 400, 500, 600, 700, 800, 1000 Hz, 
with repeat experiments performed at 50, 100, 150, and 800 Hz.  
Molecular Dynamics Simulations 
MD simulations of the CW42-H3K4me1 complex: A representative, NMR-derived conformation of 
the CW42-H3K4me1 complex and the crystal structure complex containing the E917A mutation (PDB ID: 
5YVX) were subjected to MD simulations using NAMD [8] and the CHARMM36 force field [9]. Residues 
G849 to T861 in CW42 were removed from the NMR structures since they derive from the plasmid and not 
from the ASHH2 sequence [1]. Likewise, the N-terminal Tyr-residue, present in the laboratory experiments 
to facilitate concentration measurements in the H3K4me1 peptide, was removed. A simulation of the wild-
type CW42-H3K4me1 complex without the C-terminal coil (residues G922 to A928) was also performed 
to evaluate the relevance of this part that was missing in the X-Ray structure. Finally, to compare the 
complex’s flexibility, we performed an MD simulation of the NMR structure containing the E917A 
mutation and without the C-terminal coil. In this manner, the X-Ray and NMR structures could be compared 
directly with respect to flexibility, as both simulations contained the same number of atoms. The mutant 
was prepared using Chimera from the wild-type CW42-H3K4me1 structure without the C-terminal coil. For 
a graphical representation of these setups and how they related to X-ray and NMR protein structure, please 
see Fig. 8 in the main document.  
Each system was solvated with TIP3 water molecules and neutralized with chloride and potassium ions 
using CHARMM [10]. All systems were then energy minimized prior to three equilibration steps. The first 
equilibration step consisted of a 100 ps water simulation, performed while keeping all complex coordinates 
fixed. Then, the backbone of the whole complex and the side chains of the residues W865, W874, I915, 
L919, I921, Q923, all in contact with the residue K4me1 of the H3K4me1 peptide in our structures, were 
constrained in a 500 ps equilibration. Since the X-Ray E917A mutant (PDB ID: 5YVX) contains only 
residues from E862 to I921, we did not apply the constraint on the Q923 side chain in the second 
equilibration step in this case. Finally, the systems were equilibrated for 500 ps in the NPT ensemble without 
any constraints prior to a 50 ns NPT simulation for the production phase. After equilibration, each simulation 
was done at 300 K with a time step of 1 fs. In all cases, we used Langevin dynamics with a temperature 
damping coefficient of 1 and the Langevin piston method with a pressure of 1 atm (oscillation period: 200 
fs, damping timescale: 100 fs) [11]. Coordinates of systems were written every 2 ps in the trajectory files. 
The last 46 ns of each simulation were then analyzed using VMD [12]. The Root Mean Square Deviation 
(RMSD) and the Root Mean Square Fluctuation (RMSF, using the Cα atoms) were calculated throughout 
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the simulations to evaluate the complex stability and its local flexibility, respectively. The RMSD evolution 
was calculated using the initial structure as a reference, taking into account only the backbone atoms.  
MD simulations of the CW42 apo form: The first conformation of the apo CW42 NMR structure 
(PDB ID: 2L7P) was used for MD simulations. To allow comparisons between the CW42 apo form 
simulations and those obtained for the CW42-H3K4me1 complex, we removed the first 14 residues and the 
last 9 residues in the CW42 apo form. The protocol used for the MD simulations was the same as described 
above except for the second step of equilibration. In this step, only the backbone was constrained in the 
CW42 apo forms. 
Table S1  
Selected distances between the centres of mass of amino acids (aa) of the binding site and K4me1. The table 
shows distances in the representative NMR structure before (initial structure) and during MD simulation 
(mean distance ± sd). 
Amino Acid Distance in initial 
structure (Å) 
Distance in MD 
simulation (Å) 
I915 – L919 5.80 5.59 ± 0.21 
I915 – W865 6.56 6.74 ± 0.32 
I915 – W874 7.66 6.29 ± 0.42 
L919 – W865 9.04 8.82 ± 0.82 
L919 – W874 
W865 – W874 
11.4 
5.87 
10.28 ± 0.87 






Table S2  
List of NMR experiments used in this study. 



















2D 1H-1H filtered 
TOCSY 




noesygpphwgxf.2 16 x 14 4096 x 100 32 







2D 1H-13C - HSQC hsqcetgpsi 13 x 80 1024 x 128 2 
3D 15N-
NOESYHSQC 

















noesyhsqcf3gpwg3d 14 x 35 x 14 2048 x 40 x 
128 
16 
2D 1H-13C – 
aromatic HSQC 
hsqcetgpsi 13 x 100 1024 x 256 2 
3D 13C- aromatic 
NOESYHSQC* 














noesyhsqcgpwgx13d 15 x 80 x 12 2048 x 32 x 
64 
24 
3D 13C- aromatic 
NOESYHSQC 
filter-edited 
noesyhsqcgpwgx13d 15 x 40 x 12 2048 x 32 x 
64 
24 
2D 1H-15N HSQC 
(for 1H-15N NOE) 





2D 1H-15N HSQC 
(for R1) 
hsqct1etf3gpsi3d 16 x 35 2048 x 256 8 
2D 1H-15N HSQC 
(for R2) 
hsqct2etf3gpsi3d 16 x 35 2048 x 256 8 
 2D 1H-15N HSQC  
(for CPMG RD)  
hsqcrexetf3gpsitc3d.4 16 x 35 2048 x 128 8 15N-CW42, 
15N-CW42-ARTKme1QTARY 







Table S3  
Primers used for Ligation Independent Cloning and site-directed mutagenesis of CW42. FW = forward, RV 
= reverse. Primers for making the CWs constructs are given in Hoppmann et al. 
 Forward Reverse 






CW37 (residues 858-923) 5’-CAGGGACCCGGTAGCTATTCCACAGAGAGT 5’-
GGCACCAGAGCGTTACTGTCCTATGCCCAA
CTCTTC 
CW42 (residues 861-928) 5’-CAGGGACCCGGTACAGAGAGTGCCTGGGTT 5’-
GGCACCAGAGCGTTATGCATCTGCTTCATC
CTG 




















Model choice and output summary from NESSY for the unbound state of CW42. The following resulting 
parameters were extracted: R2 – effective transverse relaxation rate at infinite υCPMG; Kex – chemical/ 
conformational exchange constant; Rex – exchange contribution to transverse relaxation; pb – population 
of the second state (where pa and pb are the populations of a two-state models with the pa is a major 
conformation, pa+pb=1); dw – chemical shift differences between states; dG and dG*– free energy 
extracted for the corresponding models; Chi2 – a measure of goodness of fit for the selected model. 
Res Model R2 [1/s] kex [1/s] Rex [rad/s] pb dw [ppm] dG at 298 
K [kj/mol] 
dG* at 298 K 
[kj/mol] 
Chi2 
861 2 7.14±3.56 1136.28±196.50 2.72±0.18 
    
16.19 
862 2 7.08±4.05 1095.87±138.49 4.07±0.21 
    
23.24 
863 2 6.83±4.62 2244.75±347.90 3.53±0.17 
    
30.32 
864 2 6.17±3.76 3854.45±1242.90 2.98±0.60 
    
23.45 
865 1 6.48±5.63 
     
45.36  
866 1 7.23±3.96 
     
35.73  
867 2 6.95±4.82 500±58.17 3.84±0.24 
    
16.97 
868 1 7.55±4.71 
     
40.57  
869 1 6.36±4.58 
     
62.05  
870 2 5±3.35 5703.38±782.76 4.38±0.42 
    
24.63 
871 1 6.92±3.57 
     
21.04  
872 2 7.39±4.66 738.62±120.21 2.80±0.23 
    
19.50 
873 1 8.04±3.65 
     
133.40  
874 2 6.63±3.51 2209.00±304.64 3.32±0.15 
    
50.47 
875 1 7.15±4.13 
     
33.67  
876 1 8.74±4.78 
     
52.44  
877 2 7.59±4.65 1492.79±282.44 3.03±0.20 
    
34.88 
878 
        
 
879 1 7.70±5.07 
     
48.24  
880 1 9.26±3.17 
     
25.43  
881 2 6.90±4.58 4943.76±2115.95 3.68±1.20 
    
15.61 
882 2 6.06±3.85 888.81±73.82 2.79±0.11 
    
14.08 
883 2 7.43±7.10 2185.81±445.06 3.47±0.26 
    
31.86 
884 1 7.36±3.34 
     
13.01  
885 2 5.84±3.30 635.14±73.61 3.18±0.21 
    
18.26 
886 3 7.88±6.80 728.25±412.04 1.89±0.33 0.005±0.122 0.124±0.068 12.75 69.43 81.27 
887 1 11.88±14.12 
     
86.12  
888 1 6.86±4.09 
     
35.54  
889 7 6.03±3.03 681.80±140.99 4.48±0.45 0.049±0.037 0.051±0.005 7.30 64.24 45.71 
890 1 7.32±5.99 
     
51.48  
891 2 6.08±3.84 2757.21±1428.67 2.09±0.49 
    
28.25 
892 1 6.29±5.16 
     
16.90  
893 1 6.70±4.43 




894 1 6.90±4.54 
     
27.17  
895 1 7.40±4.69 
     
18.16  
896 2 6.54±4.84 531.40±99.19 2.66±0.23 
    
13.67 
897 1 8.43±4.49 
     
31.52  
898 2 5.14±4.38 8062.12±1552.57 8.63±1.41 
    
46.92 
899 1 6.85±6.23 
     
62.04  
900 1 7.76±4.34 
     
17.16  
901 1 6.98±4.36 
     
31.71  
902 1 6.79±3.91 
     
15.51  
903 1 7.47±4.70 
     
21.67  
904 1 7.35±4.87 
     
28.27  
905 1 8.37±5.48 
     
38.95  
906 1 8.35±3.97 
     
31.51  
907 3 16.29±4.29 10.54±5.35 2.21±1.12 0.299±3.08E-
08 
0.814±0.248 2.09 70.13 386.74 
908 2 6.67±5.03 808.58±54.47 2.63±0.09 
    
17.59 
909 1 8.80±4.68 
     
86.94  
910 3 9.74±16.58 18.40±71.91 3.86±0.63 0.299±0.022 1.224±0.106 2.09 68.75 140.54 
911 1 7.14±4.50 
     
20.61  
912 1 9.34±3.26 
     
28.01  
913 1 7.09±5.39 
     
52.90  
914 1 7.26±4.13 
     
39.55  
915 1 5.97±5.11 
     
55.32  
916 1 6.80±5.07 
     
33.10  
917 1 7.68±4.93 
     
35.47  
918 1 6.12±4.75 
     
29.13  
919 2 8.05±7.05 1712.08±341.75 2.85±0.19 
    
15.57 
920 2 4.74±4.24 910.27±95.11 3.13±0.14 
    
15.91 
921 1 5.34±4.15 
     
28.71  
922 1 5.63±2.14 
     
15.85  
923 1 4.12±2.47 
     
37.96  
924 1 3.98±1.61 
     
55.88  
925 1 2.81±1.73 
     
62.69  
926 1 2.38±1.31 
     
127.19  
927 1 2.59±0.85 
     
104.97  
928 1 0.08±0.89 







Model choice and output summary from NESSY for the bound state of CW42. Model choice and output 
summary from NESSY for the unbound state of CW42. The following resulting parameters were extracted: 
R2 – effective transverse relaxation rate at infinite υCPMG; Kex – chemical/ conformational exchange 
constant; Rex – exchange contribution to transverse relaxation; pb – population of the second state (where 
pa and pb are the populations of a two-state models with the pa is a major conformation, pa+pb=1); dw – 
chemical shift differences between states; dG and dG*– free energy extracted for the corresponding 
models; Chi2 – a measure of goodness of fit for the selected model. 







861 1 11.88±2.55 
    
  37.96 
862 1 11.97±2.36 
    
  29.93 
863 2 15.54±3.89 500.0±23.21 1.37±0.03 
  
  12.01 
864 3 15.85±4.40 231.22±52.82 1.98±0.24 0.299±0.12 0.01±0.01 2.09 62.48 13.42 
865 2 17.06±4.50 1943.63±314.26 1.13±0.06 
  
  21.85 
866 2 16.61±4.58 2087.35±377.01 1.14±0.07 
  
  16.67 
867 1 16.76±4.60 
    
  35.66 
868 3 16.14±4.04 15.79±43.12 1.15±0.83 0.080±0.07 0.04±0.01 6.03 72.39 34.44 
869 1 15.74±4.47 
    
  26.14 
870 1 16.75±4.42 
    
  19.28 
871 1 15.78±4.22 
    
  14.35 
872 1 17.72±4.90 
    
  25.90 
873 1 18.63±4.98 
    
  25.45 
874 1 17.09±4.75 
    
  47.84 
875 2 15.95±4.29 2260.32±248.72 1.89±0.07 
  
  28.31 
876 2 16.01±3.93 1943.94±324.19 1.33±0.07 
  
  21.55 
877 1 17.84±4.78 
    
  25.48 
878 
      
   
879 1 16.00±4.16 
    
  21.80 
880 2 16.76±3.70 760.72±200.56 0.76±0.08 
  
  19.41 
881 1 19.48±5.59 
    
  35.14 
882 1 16.73±4.76 
    
  25.75 
883 1 17.03±4.59 
    
  36.91 
884 1 16.53±4.21 
    
  16.43 
885 1 16.48±4.14 
    
  14.75 
886 2 16.51±4.42 1461.86±208.63 1.04±0.05 
  
  17.04 
887 2 25.83±7.91 6382.31±3070.48 2.22±0.91 
  
  27.13 
888 1 17.46±4.19 
    
  11.52 
889 1 16.42±4.09 
    
  31.37 
890 1 27.18±8.33 
    
  45.42 
891 1 15.65±3.87 
    
  20.99 
892 1 16.85±4.92 
    
  16.36 
893 1 15.74±4.14 
    
  25.61 
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894 3 15.51±4.07 2999.99±181.70 0.90±0.06 0.003±0.06 0.23±0.09 13.77 66.92 12.58 
895 1 16.84±4.62 
    
  28.08 
896 1 17.49±4.91 
    
  28.21 
897 1 17.81±4.76 
    
  21.21 
898 1 16.76±4.28 
    
  38.76 
899 1 15.49±4.02 
    
  22.92 
900 1 17.73±4.80 
    
  14.52 
901 1 7.51±4.10 
    
  18.91 
902 1 6.91±4.37 
    
  21.23 
903 1 7.93±4.51 
    
  16.56 
904 1 7.79±4.37 
    
  12.77 
905 1 7.93±4.80 
    
  19.00 
906 1 8.09±4.52 
    
  17.29 
907 2 5.0±3.13 8363.99±2605.55 11.05±2.67 
  
  158.75 
908 1 8.45±4.86 
    
  67.91 
909 1 8.89±5.25 
    
  40.75 
910 2 6.13±4.81 5769.98±649.21 9.84±0.89 
  
  22.21 
911 2 7.87±4.69 2705.62±462.15 2.20±0.15 
  
  14.18 
912 1 8.40±4.70 
    
  40.05 
913 1 7.95±4.78 
    
  29.63 
914 1 7.58±4.75 
    
  29.81 
915 1 7.20±5.43 
    
  25.07 
916 1 7.32±4.96 
    
  32.45 
917 1 8.00±4.75 
    
  24.39 
918 1 7.32±5.11 
    
  30.71 
919 2 7.44±4.70 853.88±51.99 2.00±0.05 
  
  23.17 
920 3 7.10±4.35 65.81±36.15 6.25±1.96 0.196±0.09 0.01±0.009 3.48 66.64 17.39 
921 7 7.02±5.42 241.31±18.34 0.52±0.05 0.002±0.0002 -0.13±0.011 14.91 74.31 50.08 
922 3 6.65±3.74 214.40±16.09 4.48±0.29 0.299±0.0000001 0.013±0.0001 2.09 62.66 13.43 
923 1 5.63±2.72 
    
  12.72 
924 1 5.10±2.96 
    
  20.93 
925 1 4.74±2.34 
    
  47.19 
926 1 3.91±1.97 
    
  24.75 
927 1 4.43±1.41 
    
  54.12 
928 1 1.83±0.84 
    







Kd determinations of CWs(―),CW42(―),CW37(―) and CW33(―) for H3K4me2 and H3K4me3. 
Normalized ∆Fluorescence intensity values plotted against ligand concentrations (0.0 - 8.2 μM for 
H3K4me2, 0.0 – 15.9 μM for H3K4me3). Protein concentrations were constant throughout any one titration, 
but could vary somewhat from construct to construct (always within 2.0 - 2.4 μM). Three parallels were 
performed for each set of lignad-construct combination. The data were fitted using non-linear least-square 
methods to Eq. 1, yielding three Kd values in each instance. The Kd values given in the main document, Fig. 
1D, are averages of these. The errors quoted in Fig. 1 (main document) are one standard deviation, n = 3. 
Although the data does not plateau completely, the determined Kds were well able to differentiate between 






Loss of specific binding caused by mutations in the H3-mimicking peptide and the post-α1 loop. A) CW42 
Q923A mutant interacting with the H3K4me1 ligand. (Top) Selection of ITC heat flows in responses to 
titration of ligand in the protein solution. (Bottom) Normalized integrated peak areas. 3 out of 4 parallels 
performed are shown. B) Selection of ITC binding, CW42:H3K4me1 titrated with the T6A-modified 
peptide. (Top) Selection of ITC heat flows in responses to titration of ligand in the protein solution. (Bottom) 






Average RMSF and standard deviation of the CW constructs assessed by MD. (A) Wild type NMR 
holo and apo states, (B) the crystal structure (X-ray) and the modified NMR structure (NMR structure with 
the E917A mutation and without the C-terminal coil), (C) the wild-type NMR CW42:H3K4me1 complex 
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